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A B S T R A C T
Background
The benefits of breastfeeding are well known, and the World Health Organization recommends exclusive breastfeeding for the first six
months of life and continuing breastfeeding to age two. However, many women stop breastfeeding due to lactational breast abscesses.
A breast abscess is a localised accumulation of infected fluid in breast tissue. Abscesses are commonly treated with antibiotics, incision
and drainage (I&D) or ultrasound-guided needle aspiration, but there is no consensus on the optimal treatment.
Objectives
To assess the effects of different treatments for the management of breast abscesses in breastfeeding women.
Search methods
We searched the Cochrane Pregnancy and Childbirth Group’s Trial Register (27 February 2015). In addition we searched African
Journals Online (27 February 2015), Google Scholar (27 February 2015), ProQuest Dissertations and Theses Databases (27 February
2015) and the WHO International Clinical Trials Registry Platform (ICTRP) search portal (27 February 2015). We also checked
reference lists of retrieved studies and contacted experts in the field as well as relevant pharmaceutical companies.
Selection criteria
Randomised controlled trials (RCTs) investigating any intervention for treating lactational breast abscesses compared with any other
intervention. Studies published in abstract form, quasi-RCTs and cluster-RCTs were not eligible for inclusion.
Data collection and analysis
Two review authors independently assessed studies for inclusion, assessed risk of bias and extracted data. Data were checked for accuracy.
Main results
We included six studies. Overall, trials had an unclear risk of bias for most domains due to poor reporting. Two studies did not stratify
data for lactational and non-lactational breast abscesses, and these studies do not contribute to the results. This review is based on data
from four studies involving 325 women.
Needle aspiration (with and without ultrasound guidance) versus incision and drainage (I&D)
1Treatments for breast abscesses in breastfeeding women (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Mean time (days) to complete resolution of breast abscess (three studies) - there was substantial heterogeneity among these data
(Tau2 = 47.63, I2 = 97%) and a clear difference between subgroups (with or without ultrasound guidance; Chi2 = 56.88, I2 = 98.2%,
P = < 0.00001). We did not pool these data in a meta-analysis. Two studies excluded women who had treatment failure when they
calculated the mean time to complete resolution. One study found that the time to complete resolution of breast abscess favoured
needle aspiration over I&D (mean difference (MD) -6.07; 95% confidence interval (CI) -7.81 to -4.33; n = 36), but excluded 9/22
(41%) women in the needle aspiration group due to treatment failure. Another study reported faster resolution in the needle aspiration
group (MD -17.80; 95%CI -21.27 to -14.33; n = 64) but excluded 6/35 (17%) women in the needle aspiration group due to treatment
failure. A third study also reported that needle aspiration was associated with a shorter time to complete resolution of breast abscess
(MD -16.00; 95%CI -18.73 to -13.27; n = 60); however, the authors did not indicate the number of women who were lost to follow-
up for either group, and it is unclear how many women contributed to this result. Considering the limitations of the available data, we
do not consider the results to be informative.
Continuation of breastfeeding, after treatment (success): results favoured the needle aspiration group, but we did not pool data from
the two studies because of substantial unexplained heterogeneity (I2 = 97%). One study reported that women in the needle aspiration
group were more likely to continue breastfeeding (risk ratio (RR) 2.89; 95% CI 1.64 to 5.08; n = 60), whereas the other study found
no clear difference (RR 1.09; 95% CI 0.97 to 1.22 n = 70).
Treatment failure was more common among women treated with needle aspiration compared to those who underwent I&D (RR
16.12; 95% CI 2.21 to 117.73; two studies, n = 115, low quality evidence). In one study, treatment with needle aspiration failed in 9/
22 women who subsequently underwent I&D to treat their breast abscess. In another study, treatment with needle aspiration failed in
6/35 women, who subsequently underwent I&D. All abscesses in the I&D group were successfully treated.
The included studies provided limited data for the review’s secondary outcomes. No data were reported for adverse events. One study
(60 women) reported that women in the needle aspiration group were more satisfied with their treatment than women who received
I&D to treat their breast abscesses.
Incision and drainage (I&D) with or without antibiotics
One study (150 women) compared the value of adding a broad-spectrum cephalosporin (single dose or a course of treatment) to women
who underwent I&D for breast abscesses.
The mean time to resolution of breast abscess was reported as being similar in all groups (although women with infection were
excluded). Mean time to resolution for women who received a course of antibiotics was reported as 7.3 days, 6.9 days for women who
received a single dose of antibiotics and 7.4 days for women who did not receive antibiotics. Standard deviations, P values and CIs were
not reported and prevented further analysis. No data were reported for any continuation of breastfeeding after treatment (success).
For treatment failure, there was no clear difference between the groups of women who received antibiotics (either a single dose or a
course of antibiotics) and those who did not (RR 1.00; 95% CI 0.36 to 2.76).
Included studies rarely reported this review’s secondary outcomes (including adverse events). For post-operative complications/
morbidity, there was no difference in the risk of wound infections between the antibiotics and no antibiotics groups (RR 0.58; 95%
CI 0.29 to 1.17), irrespective of whether women received a single dose or a course of antibiotics.
Authors’ conclusions
There is insufficient evidence to determine whether needle aspiration is a more effective option to I&D for lactational breast abscesses,
or whether an antibiotic should be routinely added to women undergoing I&D for lactational breast abscesses. We graded the evidence
for the primary outcome of treatment failure as low quality, with downgrading based on including small studies with few events and
unclear risk of bias.
P L A I N L A N G U A G E S U M M A R Y
Treatments for breast abscesses in breastfeeding women
Some women develop a breast abscess while breastfeeding, called a lactational breast abscess. An abscess is a collection of infected fluid
within the breast tissue. The aim of treatment is to cure the abscess quickly and effectively, ensuring maximum benefit to the mother
with minimal interruption of breastfeeding.
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Presently, lactational breast abscesses are treated by incision and drainage or needle aspiration, with or without diagnostic ultrasound.
Antibiotics may or may not be prescribed. For incision and drainage the abscess is cut open with a scalpel (blade) to release the infected
fluid. A drain may be inserted into the wound to help the infected fluid drain or may be left open so that the infected fluid drains
naturally. A less invasive way to treat the breast abscess is by needle aspiration. A needle is inserted into the cavity of the breast abscess
and a syringe is used to draw out the infected fluid, often using ultrasound guidance. As there are advantages in using this method e.g.
no scars, reduced hospitalisation etc. the trend is to use this method more often.
We wanted to find evidence on the effectiveness of different treatments. We looked at the time taken for the abscess to heal using the
different types of treatments, the number of women who continued to breastfeed after treatment and how many women had healed in
the each group after treatment. The definition of healing varied across the studies.
We found six studies, of which four studies with a total of 325 woman contributed data. These studies compared needle aspiration
versus incision and drainage. Needle aspiration appeared to decrease the healing time compared to incision and drainage, but large
proportions of women were excluded from the analysis and it was therefore difficult to make conclusions. For the outcome continuation
of breastfeeding, both of the studies showed that women treated with needle aspiration were more likely to continue breastfeeding
compared to incision and drainage. In two studies, breast abscesses did not heal in some women who had needle aspiration and had to
be treated with incision and drainage (low quality evidence). All breast abscesses that were treated with incision and drainage healed. We
were not able to make any conclusions regarding unwanted effects or complications. Studies did not report sufficiently on the number of
follow-up visits, duration of continuation of breastfeeding, post-operative complications, duration of hospital stay and adverse events.
However, it appeared that women were more satisfied when treated with needle aspiration.
One study compared different regimens of antibiotics versus no antibiotics in breastfeeding women who were treated with incision
and drainage for breast abscesses. We did not find any difference between groups for the outcome resolution of breast abscesses and
infections after the procedure.
All of the studies were poorly conducted and/or reported and did not address all of the outcomes that we were interested in. Studies
with better design and reporting are needed to properly assess these outcomes.
3Treatments for breast abscesses in breastfeeding women (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
S U M M A R Y O F F I N D I N G S F O R T H E M A I N C O M P A R I S O N [Explanation]
Needle aspiration compared with incision and drainage for breast abscesses in breastfeeding women
Patient or population: Breastfeeding women with breast abscesses
Intervention: Needle aspirat ion
Comparison: incision and drainage
Outcomes Illustrative comparative risks* (95% CI) Relative effect
(95% CI)
No of participants
(studies)
Quality of the evidence
(GRADE)
Comments
Assumed risk Corresponding risk
incision and drainage Needle aspiration
Time to resolut ion of
breast abscess (days)
This outcome was a
dressed by three studies with severe heterogeneity (I2 = 97%), therefore the result was not pooled.
Cont inuat ion of breast-
feeding
The result for this outcome was not pooled as it was provided by two studies of small sample size with severe heterogeneity (I2 = 97%)
Treatment failure Study populat ion RR 16.12
(2.21 to 117.73)
115
(2 RCTs)
⊕⊕©©
LOW 1,2
0 per 1000 0 per 1000
(0 to 0)
Moderate
0 per 1000 0 per 1000
(0 to 0)
* The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% conf idence interval) is
based on the assumed risk in the comparison group and the relative effect of the intervent ion (and its 95%CI).
CI: Conf idence interval;
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GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our conf idence in the est imate of ef fect.
Moderate quality: Further research is likely to have an important impact on our conf idence in the est imate of ef fect and may change the est imate.
Low quality: Further research is very likely to have an important impact on our conf idence in the est imate of ef fect and is likely to change the est imate.
Very low quality: We are very uncertain about the est imate.
CI: conf idence interval; RR: risk rat io
1Evidence provided by studies of unclear risk of bias
2Included studies were of small sample size with few events (<30)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
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B A C K G R O U N D
Description of the condition
The benefits of breastfeeding arewell knownand theWorldHealth
Organization (WHO) thus recommends exclusive breastfeeding
for the first six months and continuing for up to two years and
beyond. (WHO 2003; WHO 2012). However, there are many
reasons why women stop breastfeeding; one of the most common
being the complications of lactation (Dener 2003).Of note for this
review, Amir 2004 found in a study of women who commenced
breastfeeding that 0.4% (5/1183) developed a breast abscess.
Mastitis
Mastitis is an inflammatory condition of the breast that is usu-
ally associated with lactation and that can progress from the non-
infective stage, to infective mastitis and then to a breast abscess.
The incidence of mastitis in lactating women is between 3% to
20% due to variations in the definition and follow-up in the post
partum period (Amir 2014). Mastitis is clinically characterised by
a tender, hot, swollen, wedge-shaped area of the breast associated
with high temperatures (> 38.5°C ) and flu-like symptoms. It may
or may not be accompanied by an infection (Amir 2014). Some
of the predisposing factors are limited feeding, poor positioning
of the baby, illness of mother or baby, maternal malnutrition and
cracked nipples. In infective mastitis, Staphylococcus aureus and
Staphylococcus epidermidis are the commonest causative organisms
(Amir 2014). Mastitis usually occurs during the first six weeks but
can occur at any time during lactation (Amir 2014). The primary
cause of mastitis is milk stasis (Hughes 1989). Conservative man-
agement includes efficient removal of milk, with the addition of
antibiotics for possible bacterial infections (Baker 2010;Marchant
2002). Other measures include supportive care; rest and fluids,
application of heat packs and analgesics. Antibiotics are recom-
mended if symptoms have not improved (Lawrence 2005), al-
though a Cochrane systematic review found insufficient evidence,
due to a lack of studies, to confirm or refute when to use antibi-
otics in the treatment of mastitis (Jahanfar 2012).
Lactational breast abscess
A breast abscess is defined as a localised accumulation of infected
fluid in breast tissue. Breast abscesses are usually puerperal (lacta-
tional) but can be non-puerperal (Baker 2010). Three per cent of
women with mastitis develop a lactational breast abscess ( Amir
2014).
The most common causative organism is Staphylococcus aureus
(WHO 2003), although other organisms have been identified (
Bertrand 1991; Dixon 1988; Karstrup 1993). A recent study has
suggested that methicillin-resistant Staphylococcus aureus (MRSA)
is also beginning toplay an important role (Branch-Elliman2012).
Risk factors for developing lactational breast abscesses include:
women over the age of 30, first pregnancies, gestational age ≥ 41
weeks and mastitis (Kvist 2005). A breast abscess usually presents
as a hard, tender and sometimes fluctuant mass with overlying
erythema (redness of the skin) (Barbosa-Cesnick 2003). Diagnosis
is usually made using ultrasound when a hypoechoic lesion with
an irregular border is present (Dirbas 2011).
Three Cochrane reviews (Crepinsek 2012; Lumbiganon 2012;
Mangesi 2010) have illustrated the need for education about
breastfeeding during pregnancy and to determine effective treat-
ments for the prevention of mastitis and engorgement, conditions
which contribute towards the formation of lactational breast ab-
scesses. For women at risk of developing a lactational breast ab-
scesses, it is therefore necessary to examine existing studies on treat-
ments for lactational breast abscesses, to understand its impact on
maternal health, time to recovery and its effect on breastfeeding.
Description of the intervention
Approaches to treating breast abscesses include incision and
drainage (I&D), usually carried out under general anaesthesia and
needle aspiration, which may be a single aspiration with a drain
left in situ or serial aspirations. Needle aspiration is usually done
with a local anaesthetic. Antibiotics are recommended following
either a needle aspiration or I&D (Abou-Dakn 2010). Delayed,
inappropriate or even inadequate treatment may result in more
extensive lesions and permanent tissue damage, which could affect
future lactation in about 10% of women. Breast abscesses that re-
quire extensive resection can cause disfigurement (World Health
Organization 2000).
Treatments
1. Antibiotics
Treatment of lactational breast abscesses with antibiotics, with-
out removal of pus is considered to be ineffective (World Health
Organization 2000). Following diagnostic or interventional ul-
trasound or I&D of breast abscesses, breast milk and fluid sam-
ples should be sent for culture to detect the presence of bacteria
or resistant pathogens (Amir 2014). The most commonly found
organism in a lactational breast abscess is Staphylococcus aureus
with Steptococcus orEscherichia coli being less common. Antibiotics
of choice such as dicloxacillin or flucloxacillin 500mg four times
daily orally, or the recommended sensitive local antibiotic may be
prescribed. First generation cephalosporins may also be an alterna-
tive. Women who may be allergic to penicillin may be prescribed
cephalexin or clindamycin. In cases where Staphylococcus Aureus is
resistant to penicillinase-resistant penicillins (methicillin-resistant
Staphylococcus Aureus (MRSA)) is suspected, breast milk culture
and assay of antibiotics sensitivities should be undertaken. Most
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strains of MRSA are sensitive to vancomycin or trimethoprim/sul-
phamethoxazole and less so to rifampin. One should presume that
MRSA is resistant to treatment with macrolides and quinolones
regardless of susceptibility test results (Amir 2014)
2. Surgical
Lactational breast abscesses have traditionally been treated with
I&D, but more recently there is a growing tendency to use less
invasive procedures. Where possible, all women with a suspected
lactational breast abscess should have an ultrasound, which will
be helpful in identifying all pockets of fluid. Management may
depend on the state of the overlying skin. For skin that appears
normal, drainage of the abscess is done by needle aspiration usually
with ultrasound (see below). If the skin over the abscess is thin
and shiny or the abscess appears as if it will burst, then I&D is
recommended (Dirbas 2011).
Incision and drainage is done with local or general anaesthetic. An
incision is made to allow for drainage of the infected fluid and if
a drain is required a counter incision is then made. Daily washing
out of the wound may be required until secretions decrease or
are clear. By week four, the wound should be closed and without
complications. I&D is recommended when the abscess is large
or if there are multiple abscesses. A course of antibiotics is also
advised (Abou-Dakn 2010) (see below).
3. Needle aspiration
Breast abscesses are also treated with needle aspiration, using a
local anaesthetic and under sterile conditions, with or without ul-
trasound guidance. The Society of Interventional Radiology (SIR)
defines image-guided percutaneous aspiration as “evacuation or
diagnostic sampling of a fluid collection with the use of a catheter
or a needle during a single imaging session, with removal of the
catheter or needle immediately after the aspiration” while image-
guided percutaneous drainage is defined as “the placement of a
catheter with the use of image guidance to provide continuous
drainage of a fluid collection” (Wallace 2010, p432). It may be
performed during a single session or as a staged procedure during
multiple sessions (Wallace 2010).
The (WHO (World Health Organization 2000), supports the use
of ultrasound guidance for diagnosis and treatment of lactational
breast abscesses. Ulitzsch 2004 has shown that abscesses of less
than three cm in diameter can be treated with single aspiration or
serial aspirations until resolution. Failure was seen with abscesses
greater than five cm in diameter. A probe or a drain is an alternative
to using a needle to remove the infected fluid. If the aspirate is
viscous, then a saline or antibiotic solution can be used to assist
with the aspiration. Daily aspirations are recommended until the
wound cannot be punctured anymore (< 4 mm). Serial aspirations
are done between two to nine times. A course of antibiotics is
usually recommended (Abou-Dakn 2010).
Although needle aspiration is considered as being less invasive,
not all lactational breast abscesses have been successfully treated
by this method and have subsequently needed I&D (Ozseker
2008; Ulitzsch 2004). Some of the reasons cited for treatment
failure include lack of clinical improvement, recurrence of abscess
or formation of fistulas (Giess 2014).
Breastfeeding
Prior to drainage of the breast abscess, breastfeeding should con-
tinue from the unaffected breast. Breastfeeding from the affected
breast should resume soon after drainage to prevent stasis of milk
and relapse of the infection (World Health Organization 2000).
Feeding from the affected breast is recommended, even if a drain is
in place but care should be taken to ensure that the infant’s mouth
is not in contact with the infected fluid or breast tissue (Amir
2014). Failure to allow breastfeeding lends itself to the production
of fluid that is viscous, which aggravates engorgement. Breastfeed-
ing ensures drainage of the affected area and speedy resolution of
the abscess (Walker 2011). Giess 2014 recommends that breast-
feeding can and should continue from the lactating breast with
the proviso that the prescribed antibiotics are safe for the infant.
This encourages adequate drainage, which facilitates clearing of
the infection and limits the bacterial culture medium.
How the intervention might work
The objective of any of the interventions employed in treating
an abscess is to remove the infected fluid as speedily as possible,
hastening resolution, thereby reducing the pain and discomfort
and allowing the woman to continue breastfeeding her infant with
little or no interruption. Maintaining the integrity of the breast is
also important, i.e. the procedure should leave the woman compli-
cation-free, with minimal or preferably no scarring, and the func-
tion of breastfeeding should be maintained.
Antibiotics and I&Dhave been viewed as standard therapy inman-
aging lactational breast abscesses. More recently, however, there
has been an emergence of studies favouring treatment of lacta-
tional abscesses with needle aspiration, which is considered a less
invasive technique.
Christensen 2005 favoured the use of ultrasound-guided drainage
of breast abscesses as it caused less scarring, did not affect breast-
feeding, did not require anaesthesia or hospitalisation, and was
less expensive than surgery. Although I&D has the advantage of
breaking down the loculi, if the procedure is carried out under a
general anaesthetic, it will also involve hospitalisation and regular
dressings. This is thought to cause considerable distress to both
mother and baby during what is already a difficult time and the
final cosmetic result may be unsatisfactory (Benson 1989; Dixon
1998). Scholefield 1987 expressed a similar view, suggesting that
I&D is associatedwith a prolonged healing time, regular dressings,
difficulties in breastfeeding, and the possibility of an unsatisfactory
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cosmetic outcome. Conversely Jones 1976 and Ajao 1994 found
that I&D, curettage and primary closure of the abscess cavity had
better scar formation and a reduction of cost of treatment.
Effective management of a lactational breast abscess is necessary
to eliminate discomfort and reduce the risk of discontinuation
of breastfeeding. Breastfeeding is regarded as fundamental to the
growth and development of an infant, and it is therefore impor-
tant that whatever the intervention is, it should not disrupt any
momentum gained by the mother with regards to breastfeeding
(Walker 2011).
Why it is important to do this review
There have been a number of Cochrane reviews addressing ques-
tions around prevention and treatment of breastfeeding compli-
cations (Crepinsek 2012; Lumbiganon 2012; Mangesi 2010).
Mangesi 2010 examined treatments for breast engorgement dur-
ing lactation with one of its key outcomes being mastitis and the
secondary outcome as breast abscess formation. One study showed
that there was a difference in breast abscesses between the group
that received acupuncture and those that did not, however, this
study was underpowered and the results were not statistically sig-
nificant.
Lumbiganon 2012 looked at antenatal breastfeeding education in
increasing breastfeeding duration. As a secondary outcome, they
also listed breastfeeding complications such as mastitis and breast
abscesses. The authors reported that compared to formal breast-
feeding educationplus lactation consultation versus routine breast-
feeding, education showed no significant difference inmastitis but
a significant reduction in nipple pain. Crepinsek 2012 examined
the effect of different interventions for the prevention of mastitis
following childbirth. They showed that none of the interventions
were effective in preventing mastitis. As appropriate studies were
not available at the time the review by Jahanfar 2012 was done, the
author was unable to support or deny the role antibiotics played
in treating mastitis.
A recently published non-Cochrane systematic review on the treat-
ment of breast abscesses Lam 2014 included randomised con-
trolled trials, non-randomised trials as well as case series. Partici-
pants had lactational or non-lactational breast abscesses and one
study included men. Although the authors used SORT (Strength
of Recommendation Taxonomy) to grade the quality of evidence
and the recommendations made, it is not clear how judgements
about risk of bias were made. The authors recommend the use of
needle aspiration with or without the use of ultrasound as first line
treatment of breast abscesses. No meta-analysis was conducted to
measure treatment effects.
Lam 2014 does not recommend breastfeeding from the affected
breast due to Staphylococcal organisms, which places the infant at
risk of pneumonia, lung abscesses and death. This recommenda-
tion contradicts other current literature (Amir 2014; Giess 2014).
Effective interventions for the prevention of engorgement and
mastitis are still to be determined. In the absence of these inter-
ventions there is an increased likelihood of developing a breast
abscess. Currently, there appears to be no consensus on which the
best treatment for lactational breast abscess is and to this end there
is a need to rigorously synthesise existing research to obtain clarity.
O B J E C T I V E S
To assess the effects of different treatments for the management
of breast abscesses in breastfeeding women.
M E T H O D S
Criteria for considering studies for this review
Types of studies
We included randomised controlled trials (RCTs). Trials using
cluster-randomised or cross-over designs were not eligible for in-
clusion. As per protocol, quasi-randomised trials were also ex-
cluded as we identified RCTs. Studies only reported as abstracts
were not included in the review. Future updates of this review may
consider including quasi-RCTs and cluster-RCTs (due to paucity
of data).
Types of participants
Breastfeeding women (exclusive breastfeeding or mixed-feeding)
presenting with breast abscesses in one or both breasts. Women
with co-morbidities were included (e.g. HIV, diabetes).
Types of interventions
Any intervention, surgical, non-surgical, pharmacological, non-
pharmacological, invasive, non-invasive, or a combinationof treat-
ments, to treat lactational breast abscesses, compared with any
other intervention, surgical, non-surgical, pharmacological, non-
pharmacological, invasive, non-invasive, or a combinationof treat-
ments, aimed at treating lactational breast abscesses.
Types of outcome measures
Primary outcomes
1. Time to complete resolution of breast abscess (resolution of
abscess was defined as no recurrence of abscess or need for any
intervention). Time was defined by the authors as time of
presentation for care or from time of hospitalisation.
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2. Any continuation of breastfeeding after treatment (success).
3. Treatment failure.
Secondary outcomes
1. Number of follow-up visits.
2. Duration of continuation of breastfeeding after treatment.
3. Maternal satisfaction with treatment.
4. Post-operative complications/morbidity.
5. Duration of hospital stay.
6. Adverse events.
Search methods for identification of studies
The followingmethods section of this review is based on a standard
template used by the Cochrane Pregnancy and Childbirth Group.
Electronic searches
We searched the Cochrane Pregnancy and Childbirth Group’s
Trials Register by contacting the Trials Search Co-ordinator (27
February 2015).
The Cochrane Pregnancy and Childbirth Group’s Trials Register
is maintained by the Trials Search Co-ordinator and contains trials
identified from:
1. monthly searches of the Cochrane Central Register of
Controlled Trials (CENTRAL);
2. weekly searches of MEDLINE (Ovid);
3. weekly searches of Embase (Ovid);
4. monthly searches of CINAHL (EBSCO);
5. handsearches of 30 journals and the proceedings of major
conferences;
6. weekly current awareness alerts for a further 44 journals
plus monthly BioMed Central email alerts.
Details of the search strategies for CENTRAL, MEDLINE, Em-
base and CINAHL, the list of handsearched journals and confer-
ence proceedings, and the list of journals reviewed via the current
awareness service can be found in the ‘Specialized Register’ section
within the editorial information about the Cochrane Pregnancy
and Childbirth Group.
Trials identified through the searching activities described above
are each assigned to a review topic (or topics). The Trials Search
Co-ordinator searches the register for each review using the topic
list rather than keywords.
In addition,we carried out supplementary searches of African Jour-
nals Online (27 February 2015), dissertation databases, trial reg-
istries for ongoing studies andGoogle Scholar (27 February 2015).
For dissertations we searchedProQuest Dissertations and Theses
Databases (27 February 2015). For ongoing trials, we searched the
WHO International Clinical Trials Registry Platform Search Por-
tal (ICTRP) (27 February 2015). See Appendix 1 for search terms
used in these databases.
Searching other resources
We checked the reference lists of included studies for relevant ci-
tations and contacted experts in the field in order to find any un-
published studies.We also contacted the following pharmaceutical
companies: Aspen, Glaxo Smithkline, Novartis, Pfizer and Roche
for relevant studies.
We did not apply any language or date restrictions.
Data collection and analysis
Selection of studies
Two review authors (Hayley Irusen (HI) and Anke Rohwer (AR))
independently assessed for inclusion all the potential studies iden-
tified as a result of the search strategy. We screened titles and ab-
stracts of search results to exclude irrelevant studies. We then re-
trieved full text articles of seemingly relevant studies and examined
them to see whether they met the inclusion criteria. We resolved
any disagreement through discussion and by consultation with the
third review author (Taryn Young (TY)).
Data extraction and management
We designed a form to extract data (Appendix 2). For eligible
studies, two review authors (HI and AR) extracted the data using
the agreed form.We resolved discrepancies through discussion and
consultation of a third author (TY). We entered data into Review
Manager software (RevMan 2014) and checked them for accuracy.
When information regarding any of the above was unclear, we
contacted authors of the original reports to provide further de-
tails. Of the six included studies (Chandika 2012; Eryilmaz 2005;
Naeem 2012; Saleem 2008; Singla 2002; Suthar 2012), only one
author responded in part (Naeem 2012). Where studies reported
ranges, we used BMJ online 2014 as a resource to provide the sta-
tistical method to convert ranges to mean and standard deviations
(Suthar 2012).
Assessment of risk of bias in included studies
Two review authors (HI and AR) independently made judgements
about risk of bias. Discrepancies were resolved through discussion
and by consultation with the third review author (TY) if they were
not resolved.
(1) Random sequence generation (checking for possible
selection bias)
We described for each included study the method used to generate
the allocation sequence in sufficient detail to allow an assessment
of whether it produced comparable groups.
We assessed the method as:
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• low risk of bias (any truly random process, e.g. random
number table; computer random number generator);
• high risk of bias (any non-random process, e.g. odd or even
date of birth; hospital or clinic record number);
• unclear risk of bias.
(2) Allocation concealment (checking for possible selection
bias)
We described for each included study the method used to con-
ceal allocation to interventions prior to assignment and assessed
whether intervention allocation could have been foreseen in ad-
vance of, or during recruitment, or changed after assignment.
We assessed the methods as:
• low risk of bias (e.g. telephone or central randomisation;
consecutively numbered sealed opaque envelopes);
• high risk of bias (open random allocation; unsealed or non-
opaque envelopes, alternation; date of birth);
• unclear risk of bias.
(3.1) Blinding of participants and personnel (checking for
possible performance bias)
We described for each included study the methods used, if any, to
blind study participants and personnel from knowledge of which
intervention a participant received. We considered studies at low
risk of bias if they were blinded, or if we judged that the lack of
blinding would be unlikely to affect results. We assessed blinding
separately for different outcomes or classes of outcomes.
We assessed the methods as:
• low, high or unclear risk of bias for participants;
• low, high or unclear risk of bias for personnel.
(3.2) Blinding of outcome assessment (checking for possible
detection bias)
We described for each included study the methods used, if any, to
blind outcome assessors from knowledge of which intervention a
participant received. We assessed blinding separately for different
outcomes or classes of outcomes.
We assessed methods used to blind outcome assessment as:
• low, high or unclear risk of bias.
(4) Incomplete outcome data (checking for possible attrition
bias due to the amount, nature and handling of incomplete
outcome data)
We described for each included study, and for each outcome or
class of outcomes, the completeness of data including attrition and
exclusions from the analysis. We stated whether attrition and ex-
clusions were reported and the numbers included in the analysis at
each stage (compared with the total randomised participants), rea-
sons for attrition or exclusion where reported, and whether miss-
ing data were balanced across groups or were related to outcomes.
Where sufficient information was reported, or could be supplied
by the trial authors, we re-included missing data in the analyses
which we undertook.
We assessed methods as:
• low risk of bias (e.g. no missing outcome data; missing
outcome data balanced across groups);
• high risk of bias (e.g. numbers or reasons for missing data
imbalanced across groups; ‘as treated’ analysis done with
substantial departure of intervention received from that assigned
at randomisation);
• unclear risk of bias.
(5) Selective reporting (checking for reporting bias)
We described for each included study how we investigated the
possibility of selective outcome reporting bias and what we found.
We assessed the methods as:
• low risk of bias (where it was clear that all of the study’s pre-
specified outcomes and all expected outcomes of interest to the
review had been reported);
• high risk of bias (where not all the study’s pre-specified
outcomes had been reported; one or more reported primary
outcomes were not pre-specified; outcomes of interest were
reported incompletely and so could not be used; study failed to
include results of a key outcome that would have been expected
to have been reported);
• unclear risk of bias.
(6) Other bias (checking for bias due to problems not
covered by (1) to (5) above)
We described for each included study any important concerns we
had about other possible sources of bias.
We assessed whether each study was free of other problems that
could have put it at risk of bias:
• low risk of other bias;
• high risk of other bias;
• unclear whether there is risk of other bias.
(7) Overall risk of bias
We made explicit judgements about whether studies were at high
risk of bias, according to the criteria given in the Cochrane Hand-
book for Systematic Interventions Reviews (Higgins 2011).With ref-
erence to (1) to (6) above, we assessed the likely magnitude and
direction of the bias and whether we considered it likely to impact
on the findings.
The quality of the evidence was assessed using the GRADE ap-
proach (Schunemann 2009) in order to assess the quality of the
body of evidence relating to the following outcomes for the main
comparison of needle aspiration compared to I&D.
1. Time to complete resolution of breast abscess
2. Any continuation of breastfeeding after treatment (success)
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3. Treatment failure
We usedGRADEprofiler (GRADEpro 2014) to import data from
Review Manager 5.3 (RevMan 2014) in order to create a ’Sum-
mary of findings’ table. A summary of the intervention effect and
a measure of quality for each of the above outcomes was produced
using theGRADE approach. TheGRADE approach uses five con-
siderations (study limitations, consistency of effect, imprecision,
indirectness and publication bias) to assess the quality of the body
of evidence for each outcome. The evidence was downgraded from
’high quality’ by one level for serious (or by two levels for very
serious) limitations, depending on assessments for risk of bias, in-
directness of evidence, serious inconsistency, imprecision of effect
estimates or potential publication bias.
Measures of treatment effect
Dichotomous data
For dichotomous data, we presented results as summary risk ratios
with 95% confidence intervals. Outcomes with dichotomous data
included any continuation of breastfeeding after treatment, reso-
lution of abscess, and post-operative complications/morbidity.
Continuous data
For continuous data, we used themean difference, since outcomes
were measured in the same way between trials. Outcomes with
continuous data included time to complete resolution of abscess,
number of follow-up visits, duration of continuation of breast-
feeding after treatment, maternal satisfaction with treatment and
duration of hospital stay. For length of time to resolution of ab-
scess, two studies (Chandika 2012; Saleem 2008) reported the
range of values only. In these circumstances, we estimated mean
and SD (BMJ online 2014).
Unit of analysis issues
Cluster-randomised trials were not eligible for inclusion.However,
due to paucity of data, cluster-randomised trials will be eligible for
inclusion in future updates.
Cluster-randomised trials
In future updates, we will include cluster-randomised trials in the
analyses along with individually randomised trials. We will adjust
their sample sizes or standard errors using themethods described in
the Handbook using an estimate of the intracluster correlation co-
efficient (ICC) derived from the trial (if possible), from a similar
trial or from a study of a similar population. If we use ICCs from
other sources, we will report this and conduct sensitivity analyses
to investigate the effect of variation in the ICC. If we identify both
cluster-randomised trials and individually-randomised trials, we
plan to synthesise the relevant information. We will consider it
reasonable to combine the results from both if there is little het-
erogeneity between the study designs and the interaction between
the effect of intervention and the choice of randomisation unit is
considered to be unlikely.
We will also acknowledge heterogeneity in the randomisation unit
and perform a sensitivity analysis to investigate the effects of the
randomisation unit.
Cross-over trials
Trials using a cross-over design were not eligible for inclusion in
this review as this is not an appropriate study design for the inter-
ventions in this review.
Other unit of analysis issues
Studies with two ormore than two treatment groupswere included
and were dealt with as recommended by the Cochrane Handbook
for Systematic Interventions Reviews (Higgins 2011).When a multi-
arm study contributed more than one comparison to a particular
meta-analysis, we either combined treatment groups or divided
the control group, so that the inclusion of data from the same
woman more than once in the same analysis was avoided.
Dealing with missing data
No imputation of missing data was done. Where the required
summary statistics were not reported, these were calculated from
the available data according to theCochraneHandbookChapter 7.7
(Higgins 2011), specifically where means and confidence intervals
and sample sizes per groupwere reported, standard deviationswere
calculated in the recommended manner.
For included studies, we noted levels of attrition.
For all outcomes, we carried out analyses, as far as possible, on an
intention-to-treat basis, i.e. we attempted to include all partici-
pants randomised to each group in the analyses, and analysed all
participants in the group to which they were allocated, regardless
of whether or not they received the allocated intervention. The
denominator for each outcome in each trial was the number of
participants randomised.
Assessment of heterogeneity
We assessed statistical heterogeneity in each meta-analysis using
the T², I² and Chi² statistics. We regarded heterogeneity as sub-
stantial if the T² was greater than zero and either the I² was greater
than 30% or there was a low P (less than 0.10) in the Chi² test for
heterogeneity. For significant heterogeneity, we used the random-
effects model or reported results narratively.
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Assessment of reporting biases
We did not investigate reporting biases due to the limited number
of included studies. In future updates of this review, if there are 10
or more studies in the meta-analysis we will investigate reporting
biases (such as publication bias) using funnel plots. We will assess
funnel plot asymmetry visually. If asymmetry is suggested by a
visual assessment, we will perform exploratory analyses to investi-
gate it.
Data synthesis
We carried out statistical analysis using the Review Manager soft-
ware (RevMan 2014). We planned to use fixed-effect meta-anal-
ysis for combining data where it was reasonable to assume that
studies were estimating the same underlying treatment effect: i.e.
where trials were examining the same intervention, and the trials’
populations and methods were judged sufficiently similar. Where
there was clinical heterogeneity sufficient to expect that the un-
derlying treatment effects differed between trials, or where we de-
tected substantial statistical heterogeneity (if the T² was greater
than zero and either the I² was greater than 30% or there was a
low P value (less than 0.10) in the Chi² test for heterogeneity), we
used random-effects meta-analysis to produce an overall summary,
if an average treatment effect across trials was considered clini-
cally meaningful. The random-effects summary was treated as the
average range of possible treatment effects and we discussed the
clinical implications of treatment effects differing between trials.
If the average treatment effect was not clinically meaningful, we
did not combine trials.
For random-effects analyses, the results are presented as the average
treatment effect with 95% confidence intervals, and the estimates
of T² and I².
Subgroup analysis and investigation of heterogeneity
Where we identified substantial heterogeneity, we investigated it
using subgroup analyses and sensitivity analyses. We considered
whether an overall summary was meaningful, and if it was, ran-
dom-effects analysis was used to produce it.
We planned to carry out the following subgroup analyses. We
assessed different definitions for the primary outcome.
1. Primiparas versus multigravidas.
2. Catheter aspiration (abscess ≥ 3 cm) versus needle
aspiration (abscess < 3 cm).
3. Women under 30 years of age versus those over 30 years of
age.
4. Urban settings versus rural settings.
5. Co-morbidities versus no co-morbidities.
6. Exclusive breastfeeding versus mixed breast-bottle feeding.
7. High-income settings versus low-income settings.
Due to the limited amount of data in the included studies, wewere
not able to perform any of the pre-specified subgroup analysis. In
future updates of this review, we will assess subgroup differences
by interaction tests available within RevMan (RevMan 2014). We
reported the results of subgroup analyses quoting the Chi² statistic
and P value, and the interaction test I² value.
Sensitivity analysis
We planned to perform sensitivity analysis on primary outcomes,
to examine what effect excluding those studies at high risk of bias
(for allocation concealment, and incomplete outcome data might
have on the overall result of the meta-analysis. However, since all
of the included studies were of poor quality, we did not perform
sensitivity analysis. We will carry out our planned sensitivity anal-
ysis in future updates of this review, if appropriate. In future up-
dates, if we include cluster-randomised trials in with the indivually
randomised trials, we will also carry out sensitivity analysis to in-
vestigate the effect of the randomisation unit.
R E S U L T S
Description of studies
Results of the search
The search of the Cochrane Pregnancy and Childbirth Group’s
Register retrieved four trial reports.The search for trial reports on
the Proquest dissertation and theses databases yielded 2005 stud-
ies, Google Scholar retrieved 2501 studies, African Journals on-
line database retrieved 22 studies and the WHO ICTRP search
retrieved 38 studies. Screening of reference lists yielded 30 ex-
tra studies, while contact with experts yielded no studies. Of the
pharmaceutical companies we contacted, Pfizer responded with
seven reports, which were unsuitable for inclusion as they did not
fulfil the inclusion criteria for this review of RCTS and Novartis
was unable to assist. After screening abstracts for eligibility, 15
full text articles of seemingly relevant studies were obtained. Of
these, we included six published studies (Chandika 2012; Eryilmaz
2005; Naeem 2012; Saleem 2008; Singla 2002; Suthar 2012)
and excluded nine studies (Blick 1980; Edino 2001; Florey 1946;
Ozseker 2008; Peters 1991; Sheih 2009; Strauss 2003; Tewari
2006; Wang 2013). For included studies, we contacted all of the
corresponding authors (see Characteristics of included studies).
For a summary of the search results, see (Figure 1).
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Figure 1. Study flow diagram.
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Included studies
Six studies met our inclusion criteria. Four of the studies in-
cluded 325 women (Table 1) and contributed data to the analy-
ses (Eryilmaz 2005; Saleem 2008; Singla 2002; Suthar 2012). As
the remaining two studies included lactational and non-lactational
breast abscesses and the results for the outcomes were not recorded
separately for each abscess type, the studies were not included in
the quantitative analysis (Chandika 2012; Naeem 2012) but are
described qualitatively.
Study location
One study was based in Turkey (Eryilmaz 2005), a second in
Pakistan (Saleem 2008) and two in India (Singla 2002; Suthar
2012). (Chandika 2012) was based in Uganda and (Naeem 2012)
in Pakistan. All of the included studies were conducted within a
hospital setting.
Types of intervention
The interventions included surgical (Chandika 2012; Eryilmaz
2005; Saleem 2008; Suthar 2012) as well as pharmacological in-
terventions (Singla 2002). Only one study investigated two in-
terventions against a control (Singla 2002) while each of the re-
maining five compared one intervention with another (Chandika
2012; Eryilmaz 2005; Naeem 2012; Saleem 2008; Suthar 2012).
Surgical interventions
Surgical interventions included incision and drainage (I&D)
(Chandika 2012; Eryilmaz 2005; Naeem 2012; Saleem 2008;
Suthar 2012), ultrasound-guided needle aspiration/drainage (
Saleem 2008; Suthar 2012;Chandika 2012; Naeem 2012), and
needle aspiration without ultrasound (Eryilmaz 2005). Needle as-
piration was compared with I&D in five studies (Eryilmaz 2005;
Saleem 2008; Suthar 2012; Chandika 2012; Naeem 2012). All of
the women in the studies randomised to I&D underwent general
anaesthesia (Chandika 2012; Naeem 2012; Saleem 2008; Singla
2002; Suthar 2012). Eryilmaz 2005 reported that women in the
I&Dgroup received a local anaesthetic.Women in the ultrasound-
guided needle aspiration group (Chandika 2012 Saleem 2008;
Suthar 2012), received a local anaesthetic prior to the intervention.
Participants in Naeem 2012 did not receive any local anaesthetic.
It was unclear whether the participants in Eryilmaz 2005 study
received any anaesthetic.
Intervention with antibiotics
Singla 2002 investigated different treatment regimens of a broad
spectrum antibiotic (cefazolin) compared with no antibiotics. All
three groups of women in Singla 2002 underwent I&D where the
objective of the study was to evaluate the role of antibiotics in the
management of lactational breast abscesses. One group received
intravenous cefazolin during the procedure, followed by oral cefa-
zolin for six days; the second intervention group received a single
dose of intravenous cefazolin before the procedure and the control
group did not receive any antibiotics.
Participants
The total number of women in the four studies that contributed
data was 325. Two studies included women with non-lactational
breast abscesses (Chandika 2012; Naeem 2012). In Chandika
2012 66% (43/65) of women and in Naeem 2012 83% (53/64)
presented with lactational breast abscesses. The outcomes in both
studies were not stratified according to abscess types and therefore
the data were not included in the meta-analysis.
Age and parity of women
Most women were between the ages of 20 and 30 years. One
study did not report on the age of women (Singla 2002). Saleem
2008; Chandika 2012 andNaeem 2012 included primiparous and
multiparous women. Singla 2002 and Suthar 2012 did not report
on the parity of women in their studies.
Abscess size
Abscess sizes differed between studies. Chandika 2012 and Naeem
2012 excluded all women with breast abscesses that were greater
than 5 cm. The median abscess size in Saleem 2008 was 5.5 cm
(range 2 cm to 12 cm). The mean abscess size in Suthar 2012 was
4.9 cm ± 2.5 cm (range 1 cm to 15 cm). The mean abscess size in
Eryilmaz 2005 was 6.5 ± 2.7 cm (I&D) and 6.1 ± 2.8 cm (needle
aspiration group). Singla 2002 did not report on the abscess size
of participating women.
Duration of symptoms
Duration of symptoms varied across studies.
Methods used to diagnose breast abscess
Preliminary diagnosis of an abscess was made based on clinical
features of pain, swelling, and redness of the breast associated with
localised tenderness in Suthar 2012. These women had the diag-
nosis and size of breast abscess confirmed by ultrasound evidence.
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Eryilmaz 2005 and Naeem 2012 made the diagnosis via a clinical
examination and ultrasound was not used. Saleem 2008 made the
diagnosis based on presence of a palpable mass or focal tenderness
in the clinical setting of mastitis. Singla 2002 did not report how
the diagnosis of a lactational breast abscess was made.
Outcomes
None of the studies separated outcomes into primary and sec-
ondary outcomes.
Five studies reported on time to resolution of breast abscess
(Eryilmaz 2005; Saleem 2008; Suthar 2012; Chandika 2012;
Naeem 2012), three studies reported on continuation of breast-
feeding (Saleem 2008; Naeem 2012; Suthar 2012), and three re-
ported on resolution of breast abscess (Chandika 2012; Eryilmaz
2005; Suthar 2012). Secondary outcomes were not uniformly re-
ported on in all studies. Only two of the six secondary outcomes
were addressed. Two studies reported onmaternal satisfaction with
treatment (Eryilmaz 2005; Saleem2008). Four studies reported on
post-operative complications (Naeem 2012; Saleem 2008; Singla
2002; Suthar 2012).
Definitions employed by authors
Chandika 2012 defined breast resolution as absence of symptoms
of inflammation and absence of fluid on sonar.
Naeem 2012 considered resolution of symptoms.
Saleem 2008 defined resolution as no recurrent abscess or need
for surgery.
Suthar 2012 defined resolution in the needle aspiration group as
absence of symptoms after four aspirations with no evidence of
liquefaction using ultrasound. The definitions of resolution for
the I&D group were unclear.
Eryilmaz 2005 defined time tohealing as time from I&Dto closure
for the I&D group, and time until complete resolution of the
mass up to a maximum of five aspirations for the needle aspiration
group.
For this review, we considered healing time to be the same as time
to resolution of abscess.
Excluded studies
Nine studies were excluded from the review (Blick 1980; Edino
2001; Florey 1946; Ozseker 2008; Peters 1991; Sheih 2009;
Strauss 2003; Tewari 2006; Wang 2013). Reasons for study ex-
clusions were non randomised controlled studies, non probability
sampling, absence of comparator, case series and inclusion of non-
lactational breast abscesses. Excluded studies are summarised in
the table of Characteristics of excluded studies.
Risk of bias in included studies
The risk of bias for each included study is presented in the ’Risk of
bias’ tables in the Characteristics of included studies. Figure 2 and
Figure 3 illustrate the summary of risk of bias in all the studies.
Across studies there was unclear risk of bias for most domains due
to poor reporting.
Figure 2. ’Risk of bias’ graph: review authors’ judgements about each risk of bias item presented as
percentages across all included studies.
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Figure 3. ’Risk of bias’ summary: review authors’ judgements about each risk of bias item for each included
study.
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Allocation
Random sequence generationwas assessed as adequate in one study
Chandika 2012, where a table of random numbers was generated
via a computer (Microsoft excel version 5.0).
Random sequence generation was unclear in the remaining five
studies as the authors did not adequately report on methods used
to generate a random sequence (Eryilmaz 2005; Naeem 2012;
Saleem 2008; Singla 2002; Suthar 2012).
Allocation concealmentwas unclear in all six studies asmethods for
performing allocation concealment were not described (Chandika
2012; Eryilmaz 2005; Naeem 2012; Saleem 2008; Singla 2002;
Suthar 2012).
Blinding
The nature of the intervention would have rendered it difficult
to blind personnel, participants and outcome assessors involved
in these studies. If data analysts were used and were independent
of the research team, this was not made clear in the study and
we therefore judged all studies as having an unclear risk for per-
formance and detection bias. (Chandika 2012; Eryilmaz 2005;
Naeem 2012; Saleem 2008; Singla 2002; Suthar 2012).
Incomplete outcome data
Four studies were judged as having an unclear risk of attrition
bias (Chandika 2012; Eryilmaz 2005; Singla 2002; Suthar 2012).
In Chandika 2012 four participants were lost to follow-up in the
needle aspiration group, while in the I&D group one was lost to
follow-up. It is unclear what the outcomes for these abscesses were
as this was not reported. In Eryilmaz 2005, nine participants in
the needle aspiration group were excluded from the analysis. Their
healing times were not included in the results as it was not known
how long these abscesses took to heal. The study reported the
healing rate as 41% (13/22), which is incorrect. In Singla 2002,
all results were given as percentages and therefore made it difficult
to comment on the attrition rate. In Suthar 2012, the authors
indicated that the lactational breast abscesses for 29 women had
resolved and six women were excluded from the study. It is unclear
what happened to the six women.
Naeem 2012 was judged as having a high risk of attrition due to
the fact that there were missing participants in both groups. In
addition, correspondence by the author revealed that an additional
three participantsweremissing.This informationwas not reported
in the study. In Saleem 2008, risk of incomplete outcome data
was judged high due to exclusions of participants. The authors
stated that four abscesses perforated before treatment and three
women underwent surgery because the abscesses were not suited
for ultrasound. It is unclear towhich groups thesewomenbelonged
and whether they were included in the analysis. Nine women who
had mastitis did not have breast abscesses and it is not known
whether they were exposed to any intervention and included in
the analysis.
Selective reporting
Four of the studies reported adequately on specified outcomes
(Chandika 2012; Eryilmaz 2005; Naeem 2012; Singla 2002).
Saleem2008 prespecified resolution and complication rates but re-
ported on other outcomes as well and we were therefore uncertain
if these fell under complication and resolution rate. We therefore
judged the study as having an unclear risk of bias. Suthar 2012
was judged as having unclear risk of bias as none of the outcomes
were prespecified in the methods section.
Other potential sources of bias
We judged all six studies as having an unclear risk of other po-
tential sources of bias (Chandika 2012; Eryilmaz 2005; Naeem
2012; Saleem 2008; Singla 2002; Suthar 2012). In Chandika
2012, women who were resistant to cloxacillin were removed from
the study after randomisation and the authors have not described
howmany were resistant to cloxacillin and what happened to these
women with regards to the abscess. In Naeem 2012, the authors
reported that skin indurations around abscesses were present in
93.75% of abscesses in the I&D group, whereas 71.8% of women
in the needle aspiration group had indurations. The authors re-
port that this baseline difference was significant, yet the reported P
value was 0.20, which is not statistically significant. We contacted
the authors regarding this inconsistency but no response was re-
ceived. In Saleem 2008, a table comparing baseline characteristics
between groups was not available, which made it difficult to judge
whether the groups were similar at the start of the study. In addi-
tion, groups were not treated similarly whereby in the ultrasound-
drainage group women had an ultrasound to confirm diagnosis
and resolution but it is unclear what was done for the I&D group
to confirm diagnosis and resolution. Also, the authors reported
that women who had abscesses greater than 5 cm had a catheter
inserted, but they did not report how many women had a catheter
inserted. In Singla 2002, the authors reported most of the results
as percentages and absolute numbers were not provided. The re-
port also did not contain a table of participant characteristics to
judge whether these groups were similar or not.
In Suthar 2012, a table of baseline characteristics was absent and
it was therefore difficult to judge whether women in both groups
were similar at the start of the study.
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Effects of interventions
See: Summary of findings for the main comparison Needle
aspiration comparedwith incision and drainage for breast abscesses
in breastfeeding women
1. Needle aspiration versus incision and drainage I&D)
Three studies (n = 160) were included under this comparison
(Eryilmaz 2005; Saleem 2008; Suthar 2012). In Eryilmaz 2005,
needle aspiration was done without ultrasound, while Saleem
2008 and Suthar 2012 both used ultrasound guidance for needle
aspiration. In light of heterogeneity for all three outcomes, we did
not pool data and the overall effected was not reported. Results
have been summarised in the Summary of findings for the main
comparison.
Primary outcomes
1.1 Time to complete resolution of breast abscess
Three studies reported on the mean time to complete resolution
of breast abscess (Eryilmaz 2005; Saleem 2008; Suthar 2012) - see
Analysis 1.1. Eryilmaz 2005 and Suthar 2012 excluded women
who had treatment failure when they calculated the mean time to
complete resolution.
Eryilmaz 2005 found that the time to complete resolution of breast
abscess was significantly less in the needle aspiration group com-
pared to the I&D group (mean difference (MD) -6.07; 95% con-
fidence interval (CI) -7.81 to -4.33; n = 36), but excluded 9/22
(41%) women in the needle aspiration group due to treatment
failure.
Suthar 2012 found a significant reduction in time to complete
resolution in the needle aspiration group (MD -17.80; 95% CI -
21.27 to -14.33; n = 64), but excluded 6/35 (17%) women in the
needle aspiration group due to treatment failure.
Saleem2008 also found a significant reduction in time to complete
resolution of breast abscess in the needle aspiration group (MD -
16.00; 95% CI -18.73 to -13.27; n = 60), but did not indicate the
number of women who were lost to follow-up for either group and
it is therefore not known on how many women the calculation of
average time to resolution of breast abscess was based on.
Taking into consideration the limitations of the available data of
all three studies, we do not consider the results to be informative.
1.2 Any continuation of breastfeeding after treatment
(success)
Two studies (n = 130) reported on this outcome (Saleem 2008;
Suthar 2012).Wedidnot pool the data, since therewere high levels
of unexplained heterogeneity in the random-effects meta-analysis
(Tau² = 1.38; Chi² = 32.88: P < 0.00001; I² = 97%) (Analysis
1.2).
In Saleem 2008, women in the needle aspiration group were more
likely to continue breastfeeding (risk ratio (RR) 2.89; 95%CI 1.64
to 5.08; n = 60). In Suthar 2012, continuation of breastfeeding
showed a trend towards needle aspiration, however this was not
statistically significant (RR 1.09; 95% CI 0.97 to 1.22 n = 70).
1.3 Treatment failure
Two studies (n = 115) reported on treatment failure (Eryilmaz
2005; Suthar 2012). In Eryilmaz 2005, treatment with needle
aspiration failed in 9/22 women who proceeded to have I&D. All
abscesses in the I&D group were successfully treated. In Suthar
2012, treatment with needle aspiration failed in 6/35 women,
who then underwent I&D. Treatment failure rate was high among
women who were treated with needle aspiration (RR 16.12; 95%
CI 2.21 to 117.73; participants = 115; studies = two) Analysis 1.3.
We graded this evidence as low quality (see Summary of findings
for the main comparison).
Secondary outcomes
Secondary outcomes were poorly reported in all studies and only
limited data were available to include in the analysis.
1.4 Number of follow-up visits
An assessment of the number of follow-up visits would have pro-
vided information on the recovery following the intervention.
However, no data were available. Post intervention follow-up vis-
its were not specified in Eryilmaz 2005, Singla 2002, and Suthar
2012. Saleem 2008 followed up women for up to two months
in the needle aspiration group, at weeks four and eight after the
procedure.
1.5 Duration of continuation of breastfeeding after treatment
None of the studies reported on the duration of continuation of
breastfeeding.
1.6 Maternal satisfaction with treatment
Singla 2002 and Suthar 2012 did not discuss maternal satisfaction
with the procedure. Eryilmaz 2005 reported that 16/23 (70%) of
women in the I&D group were satisfied with the outcome but did
not report on the needle aspiration group. Saleem 2008 indicated
that there was 100% (30/30) satisfaction with treatment in the
percutaneous ultrasound group whereas in the I&D group only
17/30 (55%) women were satisfied with the procedure (RR 1.74;
95% CI 1.28 to 2.38) (Analysis 1.4).
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1.7 Post-operative complications/morbidity
In Saleem 2008, one woman developed a milk fistula, 1/30 (3%)
woman had a residual abscess in the needle aspiration group, and
5/30 (16%) women developed milk fistulas in the I&D group. In
Suthar 2012, 20% (14/70) of women complained of intolerable
pain in the needle aspiration group and one woman developed a
milk fistula in the I&D group.
1.8 Duration of hospital stay
Duration of hospital stay was not reported in Suthar 2012.
Eryilmaz 2005 treated both groups ofwomenon a outpatient basis.
Saleem 2008, described having admitted (4/30) 13% of women
in the ultrasound group, but did not state for how long. The rest
of this group were treated as outpatients. The women in the I&D
group were admitted for a mean of four days (two to eight days).
1.9 Adverse events
An adverse event for this review was considered in the context
of events arising from drugs that may have been prescribed for
women during the interventions and complications associated
with the prescription thereof. None of the studies reported on ad-
verse events. Complications arising from the procedure itself were
described under post-operative complications and morbidity.
2. Incision and drainage (I&D): antibiotic use versus
no antibiotic use
One study (Singla 2002) involving 150women, compared two dif-
ferent antibiotic regimens tono antibiotic administration. All three
groups of women underwent I&D. Two of the groups were given
antibiotics andwere comparedwith a similar group of womenwho
were not given any antibiotics. Group A (n = 50) received cefazolin
1 g intravenously (IV) at the time of induction of anaesthesia and
500 mg eight hourly IV for 24 hours. This was followed by oral
cefalexin 500 mg six hourly for six days. Group B (n = 50) received
a single dose of cefazolin 1 g IV 30 minutes before surgery. Group
C (n = 50) did not receive any antibiotics.
Primary outcomes
2.1 Time to resolution of breast abscess
The mean time to resolution of breast abscess was similar in all
groups, although women with an infection were excluded. Mean
time to resolution for women who received a course of antibiotics
was 7.3 days, 6.9 days for women who received a single dose of
antibiotics, and 7.4 days for women who did not receive antibi-
otics. Standard deviations (SDs), P values and confidence intervals
(CIs) were not reported and prevented further analysis.
2.2 Any continuation of breastfeeding
The study did not report on this outcome.
2.3 Treatment failure
This study reported on recurrence of abscess, whichwas considered
as treatment failure. There was no difference between groups (RR
1.00; 95% CI 0.36 to 2.76; one study, n = 150, fixed-effect meta-
analysis). There was no difference between the group that received
a course of antibiotics and the group that received a single dose of
antibiotics (Test for subgroup differences Chi² = 0.00, P = 1.00,
I² = 0%) (Analysis 2.1).
Secondary outcomes
2.4 Number of follow-up visits
The study did not report on this outcome.
2.5 Duration of continuation of breastfeeding after treatment
The study did not report on this outcome.
2.6 Maternal satisfaction with treatment
The study did not report on this outcome.
2.7 Post-operative complications/morbidity
The only post-operative complication Singla 2002 reported on
was wound infection. There was no clear difference in the risk of
wound infections between women who received antibiotics com-
pared to women who did not receive antibiotics (RR 0.58; 95%
CI 0.29 to 1.17; one study; n = 150). There was no difference
between the group that received a course of antibiotics and the
group that received a single dose of antibiotics (Test for subgroup
differences: Chi² = 0.16, P = 0.69, I² = 0%) (Analysis 2.2).
2.8 Duration of hospital stay
The study did not report on this outcome.
2.9 Adverse events
The study did not report on this outcome.
D I S C U S S I O N
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Summary of main results
We aimed to compare interventions used for treating lactational
breast abscesses. Six studiesmet our inclusion criteria. Four of these
studies included 325 women (Table 1) and contributed data to the
analyses (Eryilmaz 2005; Saleem2008; Singla 2002; Suthar 2012).
A meta-analysis was not possible. the other two studies did not
stratify data for lactational and non-lactational breast abscesses (
Chandika 2012;Naeem2012) and these studies did not contribute
any data to the results of this review.
We did not report the overall effect for any of the outcomes, since
data obtained were of poor quality and there was significant over-
all heterogeneity. Although results for the outcome time to res-
olution of abscess favoured needle aspiration in all three studies,
Eryilmaz 2005 and Suthar 2012 excluded 9/22 (41%) and 6/35
(17%) of women respectively. These women were all in the needle
aspiration group, had treatment failure and thus underwent I&
D. Saleem 2008 did not report on any loss to follow-up. Taking
these limitations into consideration, we do not believe that these
results are meaningful. For the outcome continuation of breast-
feeding, results favoured needle aspiration. One study (Saleem
2008), showed a significant result, while the other did not (Suthar
2012). Treatment failure only occurred in the needle aspiration
groups. All women with treatment failure proceeded to have I&
D. In Eryilmaz 2005, treatment with needle aspiration failed in 9/
22 women and in Suthar 2012, treatment with needle aspiration
failed in 6/35 women.
Studies did not provide sufficient data on the number of follow-
up visits, duration of continuation of breastfeeding, duration of
hospital stay, and adverse events to contribute data for this review.
There appeared to be greater maternal satisfaction with needle
aspiration compared to I&D; it is unclear as to which procedure
is associated with complications post intervention.
Singla 2002, (n = 150 women), compared different antibiotic regi-
mens versus no antibiotics in the context of I&D. Very low quality
evidence suggests that there was no difference between groups for
the outcome treatment failure, which was defined as recurrence of
abscess in this context, and rates of infection.
Overall completeness and applicability of
evidence
One study was based in Turkey (Eryilmaz 2005), one in Pakistan
(Saleem 2008) and two in India (Singla 2002; Suthar 2012), all of
which are low- and middle-income countries. The overall sample
sizes were small, n = 160 for the comparison needle aspiration
versus I&D: and n = 150 for the comparison antibiotic use versus
no antibiotic use with I&D. None of the studies included sample
size calculations. It is thus difficult to generalise the findings of
this review across countries and settings.
It is unclear how contextual, ethnic and cultural factors may have
had an impact on the primary outcomes in the included stud-
ies. Most of the studies included women of Indian origin where
social norms and mores are a way of life, particularly during the
postpartum period and therefore may differ from cultural prac-
tices in other countries. For example, a study based in India by
(Bandyopadhyay 2009) reported thatmore thanhalf of thewomen
commenced breastfeeding 24 hours or later following childbirth
because colostrum was considered ‘harmful’ to the baby. It is not
known howmany of the women in the study were exposed to such
practices and the contribution this may have had in the devel-
opment of lactational breast abscesses. Women were also isolated
for defined periods of time because of the “impure and polluting
effects of childbirth”, an act which could potentially delay women
seeking medical assistance (Bandyopadhyay 2009 p4).
The HIV status of women in the included studies was not de-
scribed in any of the studies and it was therefore difficult to com-
ment on its impact on the primary outcomes. However, stud-
ies show that women with HIV and low CD4 counts are at in-
creased risk of developing breast abscesses (Kapatamoyo 2010).
This would be an important factor to consider especially in sub-
Saharan Africa, where HIV/AIDS prevalence is high.
Women living in high-income countries may seek treatment a lot
earlier than women living in lower-income countries, due to better
access to health facilities, available resources and insight into breast
abscess formation. These contextual factors, as well as other ethnic
and cultural factors may also affect the response to treatment of
lactational abscesses in different settings.
In the included studies, outcomes were not stratified according, to
e.g. income, setting, parity, whether infants were exclusively breast
fed, existing co-morbidities and age, which may have explained
the high levels of heterogeneity. Thus, it was not possible to assess
their impact on the primary outcomes. A range of abscess sizes
were included in the studies. The study by Suthar 2012 categorised
abscesses as > 5 cm or < 5 cm but was not stratified according
to the outcomes of interest using these ranges and would have
provided insight into resolution and time to resolution for the
different interventions.
There were missing data in all the studies. We requested infor-
mation on the missing data from all of the authors and received
no response. A more complete data set may have influenced our
results.
Singla 2002 reported that the results for the outcomes time to res-
olution and resolution of abscess as similar across all three groups
of women. It was difficult to analyse the results any further as
means and standard deviations were not provided
We were not able to pool any data in a meta-analysis. For the out-
come time to resolution of breast abscess, there were high propor-
tions of missing data and for the outcome continuation of breast-
feeding, there were high levels of unexplained heterogeneity. Data
were poorly reported across studies and outcomes were also mea-
sured differently, e.g. some used subjective measures for outcomes
like signs and symptoms, while others used objective means e.g.
ultrasound to determine resolution. In one instance, Saleem 2008
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defined what resolution was in the ultrasound group, but did not
explain how resolution was measured in the I&D group. Another
possible explanation of heterogeneity could be the lack of method-
ological rigour. It was difficult to make judgements about risk of
bias, since reporting across studies was very poor. Risk of bias was
judged as being unclear for most of the domains across studies.
Saleem 2008 was assessed as having high risk of attrition bias with
no intention-to-treat analysis done. Suthar 2012 was assessed as
having a high level of selective reporting bias.
The unexplained heterogeneity influencing the outcomesmay also
be due to factors beyond these interventions e.g. inconsistent mul-
tidisciplinary team support/approaches during and after the inter-
ventions for lactational breast abscesses.
Quality of the evidence
We used GRADE Profiler software to assess the quality of the ev-
idence by rating the quality of evidence for one of the primary
outcomes (treatment failure) under the main comparison “needle
aspiration versus incision and drainage”. Factors taken into con-
sideration include study limitations, imprecision, inconsistency
of results, indirectness of evidence and publication bias (Guyatt
2011). The evidence was graded to be of low quality for the out-
come of treatment failure. Downgrading of evidence was based on
including studies of unclear risk of bias small sample sizes with
few events. We were unable to assess the quality of findings for
the continuation of breastfeeding or time to resolution of breast
abscess - this is because the results were not pooled due to presence
of severe heterogeneity.
Potential biases in the review process
We followed theCochrane Handbook (Higgins 2011) and used the
standard methods text of the Cochrane Pregnancy and Childbirth
Group. We did not exclude studies in foreign languages and we
aimed to find all published and unpublished studies with our ex-
tensive search strategy. We obtained all relevant studies identified
from search results. We independently reviewed all potentially rel-
evant studies and resolved disagreement by discussion. Potential
bias in the review process should be minimal. We were not able to
use a funnel plot to assess reporting bias, since we only included
four studies in the review.
We considered randomised controlled trials for inclusion and
made judgements about risk of selection bias according to the stan-
dard Cochrane ’Risk of bias’ tool. None of the studies adequately
described how the random sequence was generated and we there-
fore judged them as having unclear risk of selection bias.
Agreements and disagreements with other
studies or reviews
Ulitzsch 2004, carried out a retrospective study, involving 56 lac-
tating women, to evaluate the use of ultrasound-guided needle as-
piration and concluded that ultrasound-guided needle aspiration
in women with lactational breast abscesses smaller than 3 cm, and
catheter drainage for abscesses larger than 3 cm, were useful meth-
ods in treating lactational breast abscesses
The review by Lam 2014 recommended the use of needle aspira-
tion for the treatment of breast abscesses. The authors included a
combination of 35 randomised controlled trials, non randomised
trials and case series comparing needle aspiration versus I&D of
breast abscesses. Participants had lactational and non-lactational
abscesses, and included women and men. SORT (Strength of Rec-
ommendation Taxonomy) was used to grade the evidence and
make recommendations. It is however unclear as to how risk of bias
was assessed. The review recommended needle aspiration, with or
without ultrasound as the first line of treatment of breast abscess.
Lam 2014 did not recommend breastfeeding from the affected
breast due to Staphlococcal organisms, which placed the infant at
risk of pneumonia, lung abscesses and death, and which is in con-
tradiction with current literature (Amir 2014; Giess 2014).
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
Current research is insufficient to determine whether needle aspi-
ration is a more effective option to incision and drainage (I&D)
for treating lactational breast abscesses or whether an antibiotic
should be routinely added to women undergoing I&D for lacta-
tional breast abscesses. It was difficult to determine what the influ-
ence of the interventions were on the secondary outcomes due to
the absence of data, e.g. duration of continuation of breastfeeding.
Implications for research
As needle aspiration is a less invasive method compared to I&
D, there is a need for a high-quality, large randomised controlled
trial to inform best practice. Future research design would include
studies with adequate power (sample size) and rigorous methods.
Follow-up of participants would be all-encompassing and there-
fore include duration of feeding and whether women had to sup-
plement breastfeeding as a result of the intervention used, the im-
pact of HIV, maternal morbidity and preferences for the inter-
vention, cost-analysis (the latter could ideally be considered in fu-
ture updates of this review if such information becomes available),
the number of women who recovered from the intervention and
complications in the management of lactational breast abscesses.
Consideration would be given to abscess size as there is still un-
certainty around what the optimal size would be for ultrasound-
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guided needle aspiration to be effective. High-risk groups would
be included in the sample size, e.g. smokers, rural versus urban,
younger versus older women and outcomes would be stratified
based on these risks.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Chandika 2012
Methods Study design: randomised controlled trial.
Duration of study: October 2006 and March 2007.
Participants Sample size: 65. Only 66% of the women presented with lactational breast abscesses
diagnosed using ultrasound
Inclusion criteria: women 14 years and older with breast abscesses up to 5 cm in
diameter as determined via ultrasound, who presented to the Accident and Emergency
department and breast clinic with breast abscess
Exclusion criteria: women with recurrent or chronic breast abscesses and those with
necrotic skin overlying the abscess or abscesses that were already draining. Women with
clinical features of immune suppression (WHO clinical stage 111 and 1V) and those
known to be allergic to penicillin and antibiotics were also excluded
Setting:Accident and emergency andbreast clinic ofMulagoHospital complex,Kampala
City
Country: Uganda.
Interventions 1. Ultrasound-guided needle aspiration (n = 33)
This was done in the department of radiology ultrasound room in the OPD. Aspiration
was done using ultrasound guidance using local anaesthetic. Infected fluid samples were
sent for culture and sensitivity. Aspiration was done until there was no infected fluid.
Cloxacillin 500 mg orally 8 hourly for 10 days and Diclofenac 75 mg IM stat and 50
mg 8 hourly for 3 days respectively. Follow-up was done via the OPD by the principal
investigator on days 7, 14 and 30. If abscess persisted, aspiration was done on day 7,
if it persisted on day 14 - this was considered treatment failure. The women was then
sent for I&D. Women were asked to resume breastfeeding on both breasts as soon pain
during breastfeeding was tolerable
2. Incision and drainage (n = 32)
Procedure was done in the operating theatre under general anaesthesia. Women were
hospitalised overnight and discharged the next day. The participant was placed in a
supine position. The affected breast was swabbed using Chlorhexidine Centrimide. A
skin incision was made at the area of maximum fluctuation along skin lines and a sinus
forceps used to reach the abscess cavity. Infected fluid samples were sent for culture and
sensitivity. The infected fluid was then evacuated and loculi broken down digitally, the
wound was then packed with sterile gauze. Dicolfenac 75 mg injection (IM) stat and 50
mg 8 hourly for 3 days Cloxacillin 500 mg 8 hourly for 10 days. On discharge, wound
dressings were done at nearby clinic until the wound healed. Women who were resistant
to Cloxacillin were excluded from the study and antibiotics changed based on sensitivity
studies. Women were asked to resume breastfeeding on both breasts as soon pain during
breastfeeding was tolerable
Outcomes Authors did not differentiate between primary and secondary outcomes
Time to breast abscess resolution.
Breast abscess recurrence.
Acceptance of ultrasound-guided needle aspiration procedure.
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Chandika 2012 (Continued)
Cost of the procedure.
Definition of healing: healing was defined as achieving breast abscess resolution. Breast
abscess resolution was defined as clinically no breast tenderness, swelling or wound at
previous site of abscess and sonographically complete absence of fluid collection, normal
breast glandular and fibro fat tissue with no edema
Notes Funding: not reported.
Conflict of interest: the authors declared no competing interest.
Ethics approval: approval issued by Faculty of medicine research committee, National
science and research council, Mulago hospital complex and the Department of surgery,
Mulago hospital
Author contacted: yes, no response received.
Below are the questions sent to the authors via email:
1. Is there a copy of the protocol available? If so we would be very grateful to get a
copy.
2. Can the authors also indicate what the numbers were lactating in the Ultrasound
versus the I&D group included in the study. If numbers on parity (primi, multi or
nulliparous) for the two groups are available are we able to request those as well?
3. Is there any information on duration of breastfeeding in both groups, i.e. the
number that were breastfeeding before the interventions and those that continued after
and if so for how long?
4. The review team also needs clarity about the following. The following are the
numbers included in study; I&D N = 32 Ultrasound-guided aspiration (UGA) = 33.
Loss to follow-up: I&D = 1; UGA = 4. The loss to follow-up is taken from Figure 2.
Therefore the numbers should be I&D group N = 31 and UGA group N = 29. In light
of this can you please clarify the difference in the numbers in Table 1: the total healing
rates per group: Group A = 29 and Group B = 28? The authors indicate that there was
no conversion to I&D from the ultrasound group.
5. It was suggested that “Patients whose culture and sensitivity results showed
resistance to Cloxacillin were excluded from the study and antibiotic treatment
changed accordingly”. Can you advise how many patients were excluded from the
study for ultrasound arm and did this apply to the incision and drainage arm as well?
6. Could the authors also clarify in Table 2 whether mean healing time was meant to
read weeks or days?
7. Lastly, the study indicated 100% maternal satisfaction with the ultrasound
guidance -do you have the numbers for the Incision and drainage group?
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Microsoft Excel version 5 was used to gen-
erate a random number list
Allocation concealment (selection bias) Unclear risk Not stated.
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Although there was no blinding this would
not affect the resolution of the abscess
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Chandika 2012 (Continued)
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk The authors reported that no blinding was
done. However blinding of outcome asses-
sors is not possible due to the nature of
the interventions and therefore difficult to
judge whether this has an impact
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk 33 women were randomised to the ultra-
sound needle aspiration group with 32 al-
located to the I&D group. The authors in-
dicated that 29 were effectively treated by
ultrasound-guided needle aspiration group
and 31 in the incision group with no rea-
son being given. These numbers have not
been included in the analysis and no ITT
was done. Authors contacted and awaiting
response
Selective reporting (reporting bias) Low risk All outcomes prespecified in the methods
section have been addresses
Other bias Unclear risk Women in both arms were excluded from
the study if they were shown to be resis-
tant to cloxacillin after randomisation and
it is not known how many women were re-
sistant to cloxacillin in both arms. Authors
declared no conflict of interest
Eryilmaz 2005
Methods Study design: prospective RCT.
Duration of study: January 2000 to July 2003.
Participants Sample size: 45.
Inclusion criteria: lactatingwomenwith breast abscesses presenting at the surgical clinic.
Women were treated for mastitis prior to development of the abscess
Exclusion criteria: not reported.
Setting: Department of surgery Vakif Gureba training hospital, Instanbul
Country: Turkey.
Interventions 1. Incision and drainage (n = 23)
The procedure was done via the surgical OPD using local anaesthesia . The abscess
was incised and the infected fluid was evacuated. The wound was left open to drain
and dressed daily until the wound healed. A sample of the infected fluid was sent for
bacteriological examination. Antibiotics were prescribed post-operatively. Women were
encouraged to feed from the unaffected breast and the breast with the abscess was emptied
using breast pump
2. Needle aspiration. Ultrasound guidance was not used (n = 22)
It is unclear as to whether any anaesthesia was used during this intervention
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Eryilmaz 2005 (Continued)
Aspirations were repeated on alternate days until the abscess had completely resolved or
until 5 needle aspirations had been performed. A sample of the infected fluid was sent for
bacteriological examination. Antibiotics were prescribed post-operatively Breastfeeding
as per I&D group
Outcomes Primary outcomes and secondary outcomes. Authors did not differentiate between pri-
mary and secondary outcomes
1. Results of pus culture.
2. Healing rate.
3. Healing time.
4. Recurrence.
5. Cosmetic outcome-incision and drainage.
6. Pus volume.
7. Number of aspirations.
Definition of healing for incision and drainage group: healing was defined as time from
incision and drainage to wound closure
Definition of failure for needle aspiration group: if after 5 aspirations which were done
every other day the abscess was not resolved, this was considered a failure of treatment
Notes Funding: not reported.
Ethics approval: not stated. Informed consent obtained from the participants
Author contacted: yes, no response received. Below are the questions sent to the authors
via email
1. Can you please advise on what system of randomisation was used?
2. Was any method of allocation concealment used?
3. At any stage of the study were assessors blinded and if so can you advise as to who
these were?
4. Can you advise on the mean and standard deviation of the patients that failed
ultrasound drainage and had to have incision and drainage of abscess?
5. Table 1 -Healing rate for the needle aspiration group is 13 (41%) There seems to
be an error with the percentage-can you please advise, we estimate it to be 59%
6. Is it also possible for us to have a copy of your protocol for information that is
generally not given in papers?
7. Can you advise if the patients in the needle aspiration group received any
anaesthesia?
8. Can you please clarify what mean duration of lactation (line3) refers to (26% and
36% respectively)? Is this meant to read duration of lactation after procedure?
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Women were randomised 1:1. Method of
randomisation not reported
Allocation concealment (selection bias) Unclear risk Not described.
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Eryilmaz 2005 (Continued)
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Although there was no blinding, it is un-
clear whether the resolution of the abscess
would be affected
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk No blinding was done. Blinding of out-
come assessors is not possible due to the na-
ture of the interventions and therefore dif-
ficult to judge whether this has an impact
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk 9 women were excluded from the analysis
in the needle aspiration group (mean heal-
ing time). The authors have not described
how long the abscesses took to heal even
after I&D
Selective reporting (reporting bias) Low risk All prespecified outcomes were reported
on.
Other bias Unclear risk Funding: authors did not declare any com-
peting interests.
Ethics approval: not stated. Informed con-
sent obtained from the participants
Author contacted: yes.
Naeem 2012
Methods Study design: RCT
Duration of study: August 2008 and August 2010
Participants Sample size: 64 (only 52 (86.67%) were lactational breast abscesses. From the text it
appears that 11 had non-puerperal breast abscesses, but that the percentages do not
correspond to the actual numbers. We have contacted authors for clarification
Inclusion criteria:
Any female with a single abscess smaller than 5 cm in a reproductive-aged group who
was not pregnant at the time and not being treated for any other breast pathology
Exclusion criteria:
Women with sinus/fistula of breast abscess, prolonged history and necrosis of the skin
Setting: KVVS hospital, Karachi.
Country: Pakistan.
Interventions 1. Incision and drainage (n = 32)
The intervention was carried out in a hospital setting. Women were admitted between
1 to 3 days. A general anaesthetic was given. Before surgery the infected fluid was sent
for culture and sensitivity and cytology. 625 mg capsule of co-amoxiclav 3 times a day
were and 400 mg metronidazole (non-lactational breast abscesses) until culture reports
were received. IV analgesia was initially given. IM analgesia was initially given and then
followed by oral analgesia. Daily dressings were for 1 to 3 weeks Women were followed
up for 8 weeks after the procedure. Women were unable to feed with the affected breast
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so milk was discarded after expressing with breast pump according to the authors
2. Ultrasound-guided needle aspiration. (n = 32)
The procedure was done in the OPD therefore requiring no hospital admission. No
anaesthetic was given. The aspiration was done using ultrasound guidance. Prior to the
procedure, samples were sent for culture and sensitivity and cytology. 625 mg capsule
of co-amoxiclav 3 times a day and (400 mg metronidazole) was given to non-puerperal
abscesses. The cavity waswashedwith normal saline and a follow-up ultrasoundwas done
on the third day. If the abscess was seen, the canula was left in place. IM analgesia was
initially given. Follow-up was done for 8 weeks after the procedure. Women continued
to feed
Outcomes Authors did not differentiate between primary and secondary outcomes
1.Time taken to resolve symptoms (point tenderness; erythema; hyperthermia)
2.Recurrence of breast abscess
3.Healing time
Notes Funding: not reported.
Conflict of interest: authors did not declare any competing interests.
Ethics approval: not stated.
Author contacted: Partial response received from corresponding author below:
“Our review is assessing puerperal breast abscesses only and the management thereof”
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk It is not stated how they were randomly
divided.
Allocation concealment (selection bias) Unclear risk Not stated.
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Although there was no blinding the resolu-
tion of the abscess would not be affected
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Blinding of outcome assessors is not possi-
ble due to the nature of the interventions
and therefore difficult to judge whether this
has an impact
Incomplete outcome data (attrition bias)
All outcomes
High risk Table 1: Group A, n = 32 however out-
comes for 30 only addressed. For group B
there is also one missing, the values only
add up to 31. The response from the author
was that in the analysis there were: Group
A - 30 women and group B 31. Upon re-
questing information from the correspond-
ing author he mentioned that 3 partici-
pants were missing at week 8 follow-up -
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no reasons were given as to what happened
to them. This information was not in the
study
Selective reporting (reporting bias) Low risk Healing time was addressed and abscess re-
currence.
However with regards to time to resolv-
ing of symptoms, only breast pain was ad-
dressed, erythema and hyperthermia not
addressed
Other bias Unclear risk The authors report that skin indurations
around abscesses were present in Group A
in 93.75% whereas in Group B only 71.
8%. They say the P value is significant, but
it is 0.20. There is also no table of baseline
characteristics of both groups, so we cannot
really judgewhether therewere any baseline
differences between groups
Saleem 2008
Methods Study design: RCT.
Duration of study: Jan 2005 to June 2007.
Participants Sample size: 60.
Inclusion criteria: women with clinically suspected breast abscesses. All women had
mastitis
Exclusion criteria: not given.
Setting: Allied Hospital, Faisalabad.
Country: Pakistan.
Interventions 1. Percutaneous drainage under ultrasound guidance (n = 30)
26/30 women had needle aspiration done via OPD and 4/30 were admitted to hospital.
Only women with abscesses larger than 3 cm were given an anaesthetic. The abscess
was diagnosed using ultrasound. An ultrasound-guided needle puncture was made to
confirm the diagnosis. Samples of the infected fluid were sent for culture and sensitivity.
Abscesses that were smaller than 3 cm were aspirated; for those that were 3 cm and larger
a catheter was inserted to allow the abscess to drain. The wound was irrigated 3 to 5 times
with sterile saline until the aspirate ran clear. Antibiotics were prescribed. Women were
followed up to 2 months. Women who were discharged with catheters were taught how
to clean the catheter. On return to the facility, the catheter was removed when abscess
was no longer visible on ultrasound. Women were encouraged to breastfeed
2. Incision and drainage (n = 30)
30 women were admitted to hospital for a mean duration of 4 days. General anaesthetic
was given. Samples of the infected fluid were sent off for culture and sensitivity. Antibi-
otics were prescribed. Women were followed up to 2 months. Daily dressings were done.
Women were encouraged to breastfeed
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Outcomes Primary outcomes and secondary outcomes. Authors did not differentiate between pri-
mary and secondary outcomes
1. Healing time.
2. Complications (recurrent breast abscess, breastfeeding cessation, fistula).
3. Resolution was defined as no recurrent abscess and no need for surgery where
resolution will be the same as healing time.
Notes Funding: not reported.
Conflict of interest: authors did not declare any competing interests.
Ethics approval: not indicated. Informed consent obtained.
Author contacted: yes and no response received. Below are the questions sent to the
authors via email
1. Can you describe how women were randomised?
2. Was there allocation concealment e.g. someone off site allocating women?
3. The study referred to 4 women spontaneously rupturing and 3 women with
abscesses that were not suitable for ultrasound. Was this during women selection or
after women were randomised? Which groups did they belong to? Were they included
in the study/analysis?
4. Are you able to say of the 30 women who had the ultrasound drainage, how many
had catheters left in situ?
5. Did women in the incision and drainage group have an ultrasound to diagnose
their abscess?
6. The 9 women who did not have an abscess, were they included in the analysis of
results?
7. Do you have a table of baseline characteristics for the patients in the study?
8. Are able to give a mean and SD2 for time to resolution?
9. We would like to know what the absolute numbers are for acceptance by women
for both the ultrasound drainage and incision and drainage please
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Not described. Authors only state that par-
ticipants were “divided into two groups
randomly”
Allocation concealment (selection bias) Unclear risk Not stated.
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Although blinding was not done this may
not have affected resolution
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not described. Blinding of outcome asses-
sors is not possible due to the nature of
the interventions and therefore difficult to
judge whether this has an impact
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Incomplete outcome data (attrition bias)
All outcomes
High risk Authors state that 4 women had abscesses
that perforated before treatment, 3 women
underwent surgery because the abscesses
were not suited for ultrasound drainage.
Authors do not state to which group these
women belonged and whether they were
included in the analysis or not. In group
A, 9 participants did not have breast ab-
scesses, and it is uncertain if these women
were included in the analysis since there is
no mention of the sample size for table III.
In the I&D group it is unclear if all women
were operated on regardless of whether they
had an abscess or if there was an obvious
diagnosis of a breast abscess and were all
allocated to Group B. It is for these reasons
that it was assessed as high risk
Selective reporting (reporting bias) Unclear risk Authors only pre-specified resolution rate
and complications. They described recur-
rence, breastfeeding cessation, fistulas. It
was unclear if the latter was considered un-
der the banner of complications and there-
fore was assessed as unclear
Other bias Unclear risk We did not have a table comparing baseline
characteristics between groups. This made
it very difficult to judge whether groups
were actually similar at the start of the study
Also, groups were not treated equally.
Group A had ultrasound to confirm diag-
nosis and resolution of abscess andwere un-
clear how was this done in group B as it
was not reported. We were also uncertain
as to whether participants in Group A had
a catheter inserted or only aspiration
Singla 2002
Methods Study design: prospective RCT.
Duration of study:1989 to 1998.
Participants Sample size: n = 150; 50 women per group.
Inclusion criteria: women with lactational breast abscesses.
Exclusion criteria: women with diabetes (3) and those on previous antibiotics (29) were
excluded from the study
Setting: Department of surgery, Pt PD Sharma PGIMS, Rohtak Haryana, PIN-124001,
India
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Country: India.
Interventions Women in all 3 groups women were treated with I&D under general anaesthetic for
their abscesses. Women in group A and B were then given a broad spectrum antibiotic
and compared to group C, a control group
Group A: n = 50. Women received cefazolin (1 g) IV at the time of induction of
anaesthesia and 500 mg 8 hourly IV for 24 hours. This was followed by cefalexin (500
mg) capsules for 6 hourly for 6 days
Group B: n = 50.Women received IV cefazolin (1 g), given IV 30minutes before surgery
only
Group C: n = 50. Women were not given any antibiotics.
Under general anaesthesia the abscess was drained and the infected fluid sent for culture
and sensitivity. The cavity was curetted and packed for 5 minutes. It was then washed
with normal saline with visible active bleeders ligated and the wound closed over a suction
drain. The cavity was not obliterated. Three blood culture specimens were taken, one
at 30 minutes before the procedure, one at 30 minutes after the procedure and the last,
an hour after the procedure. It is unclear as to what procedures were followed after the
intervention nor the advice on lactation if any
Outcomes Primary outcomes and secondary outcomes. Authors did not differentiate between pri-
mary and secondary outcomes
1. Amount and nature of drainage fluid
2. Wound infection
3. Healing time
4. Recurrences
Notes Funding: not reported.
Conflict of interest: authors did not declare any competing interests.
Ethics approval: not described. Only informed consent taken from women.
Author contacted: the hospital director was contacted via email for contact details of
author. No response received
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Authors say women were “randomly allo-
cated” but did not describe how this was
done
Allocation concealment (selection bias) Unclear risk This was not described.
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Although there was no blinding the resolu-
tion of the abscess would not be affected
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not described. Blinding of outcome asses-
sors is not possible due to the nature of
the interventions and therefore difficult to
34Treatments for breast abscesses in breastfeeding women (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Singla 2002 (Continued)
judge whether this has an impact
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Difficult to say as all results are reported in
percentages.
Selective reporting (reporting bias) Low risk All outcomes prespecified in the methods
section were addressed
Other bias Unclear risk The study does not contain a lot of de-
tail. Baseline characteristics for participants
were not provided and cannot be certain if
women in the groups were similar. The lat-
ter makes it difficult to determine whether
participants in the various groups were the
same
Suthar 2012
Methods Study design: RCT.
Duration of study: not stated.
Participants Sample size: 70.
Inclusion criteria: women with puerperal breast abscess.
Exclusion criteria: women with diabetes mellitus, renal failure, steroid therapy, sus-
pected malignancy, history of malignancy, recurrent breast abscess, active pulmonary
TB, tuberculous lymphadenitis, sub-areolar breast abscess imminent necrosis of skin on
breast were all excluded
Setting: not described. It is unclear from where the participants were sourced
Country: authors are based in Gujarat India.
Interventions 1. Percutaneous ultrasound-guided needle aspiration (n = 35)
Women were treated on an OPD basis. Local anaesthesia was given. Post-procedural
ultrasound images were obtained to evaluate residual fluid collections. Aspirations were
done at 4- to 5-day intervals until resolution, using ultrasound evidence, which was
considered as an end point of management. Treatment was considered a failure after
4 aspirations and with evidence of liquefaction. Oral antibiotics were prescribed. It is
unclear whether women had to adhere to post discharge visits though all women were
encouraged to breastfeed under hygienic conditions
2. Open surgical drainage under general anaesthetic indoors (n = 35)
Women were hospitalised and the procedure was done using general anaesthetic. Daily
dressings with packing gauze were carried out until signs and symptoms resolved and
there was ultrasound evidence of complete healing. Oral antibiotics were prescribed.
Women were encouraged to feed from the opposite side and to express milk from the
operated side. It is not known what the post discharge procedures were as these were not
described
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Outcomes Primary outcomes and secondary outcomes. Authors did not differentiate between pri-
mary and secondary outcomes
1. Time to resolution
2. Complications
Failure for the ultrasound group was defined as persistence of signs and symptoms after
4 aspirations with ultrasound evidence of liquefaction
Notes Funding: not reported.
Conflict of interest: authors did not declare any competing interests.
Ethics approval: the authors do not state whether this was received. Consent was ob-
tained from women
Author contacted: yes and no response received. Below are the questions sent to the
authors via email
1. Can you please advise on what method was used to do the random sampling e.g.
was a table of random numbers used?
2. Can you also advise whether allocation concealment was done and if so how this
was done?
3. When measuring outcomes, were assessors blinded?
4. Is there a flow diagram (or description) from the point when women were
recruited to when outcomes were being measured, attrition level etc? If this is available
can you kindly let us have access to this?
5. Is a table of baseline characteristics available for the different groups?
6. We also need a mean healing time and SD for both groups? If this is not available
can you allow us to get the individual participant data so that we can work out the
mean and SD?
7. Was there any recurrence in the incision and drainage group as this was only given
for the percutaneous ultrasound group?
8. We would also like information and numbers on the level of acceptance of the
procedure in the incision and drainage group and the numbers for the acceptance level
for the ultrasound group if this is available.
9. We have tried searching the trial registries web site for a copy of the protocol
could you kindly let us have a copy of this as it will give us information that is generally
not given in a report?
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Not described as authors only state that
they made use of “random sampling”
Allocation concealment (selection bias) Unclear risk Not reported on.
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Not described. Although blinding was not
described the resolution of the abscess
would not be affected
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Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not described. Blinding of outcome asses-
sors is not possible due to the nature of
the interventions and therefore difficult to
judge whether this has an impact
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk All participants were accounted for. The
number of participants were deduced from
the tables provided. No flow chart was pro-
vided and nowhere do they mention how
many participants were allocated to the dif-
ferent groups
Selective reporting (reporting bias) Unclear risk Although all stated outcomes were dis-
cussed. These were not prespecified in the
methods section
Other bias Unclear risk There is no table of baseline characteristics
of participants, therefore very difficult to
judge whether groups were similar at the
start of the study
I&D: incision and drainageI
IM: intramuscular
ITT: intention-to-treat
IV: intravascular
OPD: outpatients department
RCT: randomised controlled trial
SD: standard deviation
stat: immediately
TB: tuberculosis
UGA: ultrasound-guided aspiration
Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Blick 1980 A variety of abscesses were presented with only 3/80 puerperal abscesses
Edino 2001 Prospective study.
Florey 1946 This is not a comparative study, it looks at cases that presented and were treated
Ozseker 2008 Case series.
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Peters 1991 No comparator group.
Sheih 2009 Non probability convenience sampling and different outcomes for intervention and comparator groups
Strauss 2003 Retrospecitve case series, not a clinical trial.
Tewari 2006 No comparator group, descriptive study.
Wang 2013 No comparator group, descriptive study.
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D A T A A N D A N A L Y S E S
Comparison 1. Needle aspiration versus incision and drainage (ultrasound guided versus no ultrasound guided)
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Time to resolution of breast
abscess (days)
3 Mean Difference (IV, Random, 95% CI) Totals not selected
1.1 Needle aspiration without
ultrasound
1 Mean Difference (IV, Random, 95% CI) 0.0 [0.0, 0.0]
1.2 Needle aspiration with
ultrasound
2 Mean Difference (IV, Random, 95% CI) 0.0 [0.0, 0.0]
2 Continuation of breastfeeding 2 Risk Ratio (M-H, Random, 95% CI) Subtotals only
3 Treatment failure 2 115 Risk Ratio (M-H, Random, 95% CI) 16.12 [2.21, 117.73]
4 Maternal satisfaction with
treatment
1 60 Risk Ratio (M-H, Fixed, 95% CI) 1.74 [1.28, 2.38]
Comparison 2. Incision and drainage: antibiotic use versus no antibiotic use
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Treatment failure 1 150 Risk Ratio (M-H, Fixed, 95% CI) 1.0 [0.36, 2.76]
1.1 Course of antibiotics 1 75 Risk Ratio (M-H, Fixed, 95% CI) 1.0 [0.20, 5.09]
1.2 Single dose of antibiotics 1 75 Risk Ratio (M-H, Fixed, 95% CI) 1.0 [0.27, 3.67]
2 Post-operative complications 1 150 Risk Ratio (M-H, Fixed, 95% CI) 0.58 [0.29, 1.17]
2.1 Course of antibiotics 1 75 Risk Ratio (M-H, Fixed, 95% CI) 0.67 [0.26, 1.71]
2.2 Single dose of antibiotics 1 75 Risk Ratio (M-H, Fixed, 95% CI) 0.5 [0.18, 1.39]
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Analysis 1.1. Comparison 1 Needle aspiration versus incision and drainage (ultrasound guided versus no
ultrasound guided), Outcome 1 Time to resolution of breast abscess (days).
Review: Treatments for breast abscesses in breastfeeding women
Comparison: 1 Needle aspiration versus incision and drainage (ultrasound guided versus no ultrasound guided)
Outcome: 1 Time to resolution of breast abscess (days)
Study or subgroup Needle aspiration Incision and drainage
Mean
Difference
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 Needle aspiration without ultrasound
Eryilmaz 2005 13 6.36 (2.43) 23 12.43 (2.76) -6.07 [ -7.81, -4.33 ]
2 Needle aspiration with ultrasound
Saleem 2008 30 5 (3) 30 21 (7) -16.00 [ -18.73, -13.27 ]
Suthar 2012 29 8.5 (5.7) 35 26.3 (8.4) -17.80 [ -21.27, -14.33 ]
-50 -25 0 25 50
Favours needle aspiration Favours I%D
Analysis 1.2. Comparison 1 Needle aspiration versus incision and drainage (ultrasound guided versus no
ultrasound guided), Outcome 2 Continuation of breastfeeding.
Review: Treatments for breast abscesses in breastfeeding women
Comparison: 1 Needle aspiration versus incision and drainage (ultrasound guided versus no ultrasound guided)
Outcome: 2 Continuation of breastfeeding
Study or subgroup Needle aspiration Incision and drainage Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Saleem 2008 26/30 9/30 2.89 [ 1.64, 5.08 ]
Suthar 2012 35/35 32/35 1.09 [ 0.97, 1.22 ]
Test for subgroup differences: Not applicable
0.05 0.2 1 5 20
Favours I%D Favours needle aspiration
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Analysis 1.3. Comparison 1 Needle aspiration versus incision and drainage (ultrasound guided versus no
ultrasound guided), Outcome 3 Treatment failure.
Review: Treatments for breast abscesses in breastfeeding women
Comparison: 1 Needle aspiration versus incision and drainage (ultrasound guided versus no ultrasound guided)
Outcome: 3 Treatment failure
Study or subgroup Needle aspiration Incision and drainage Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Eryilmaz 2005 9/22 0/23 50.9 % 19.83 [ 1.22, 321.41 ]
Suthar 2012 6/35 0/35 49.1 % 13.00 [ 0.76, 222.31 ]
Total (95% CI) 57 58 100.0 % 16.12 [ 2.21, 117.73 ]
Total events: 15 (Needle aspiration), 0 (Incision and drainage)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.04, df = 1 (P = 0.83); I2 =0.0%
Test for overall effect: Z = 2.74 (P = 0.0061)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours needle aspiration Favours I%D
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Analysis 1.4. Comparison 1 Needle aspiration versus incision and drainage (ultrasound guided versus no
ultrasound guided), Outcome 4 Maternal satisfaction with treatment.
Review: Treatments for breast abscesses in breastfeeding women
Comparison: 1 Needle aspiration versus incision and drainage (ultrasound guided versus no ultrasound guided)
Outcome: 4 Maternal satisfaction with treatment
Study or subgroup Needle aspiration Incision and drainage Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Saleem 2008 30/30 17/30 100.0 % 1.74 [ 1.28, 2.38 ]
Total (95% CI) 30 30 100.0 % 1.74 [ 1.28, 2.38 ]
Total events: 30 (Needle aspiration), 17 (Incision and drainage)
Heterogeneity: not applicable
Test for overall effect: Z = 3.48 (P = 0.00049)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours I%D Favours needle aspiration
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Analysis 2.1. Comparison 2 Incision and drainage: antibiotic use versus no antibiotic use, Outcome 1
Treatment failure.
Review: Treatments for breast abscesses in breastfeeding women
Comparison: 2 Incision and drainage: antibiotic use versus no antibiotic use
Outcome: 1 Treatment failure
Study or subgroup Antibiotics No antibiotics Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Course of antibiotics
Singla 2002 4/50 2/25 40.0 % 1.00 [ 0.20, 5.09 ]
Subtotal (95% CI) 50 25 40.0 % 1.00 [ 0.20, 5.09 ]
Total events: 4 (Antibiotics), 2 (No antibiotics)
Heterogeneity: not applicable
Test for overall effect: Z = 0.0 (P = 1.0)
2 Single dose of antibiotics
Singla 2002 6/50 3/25 60.0 % 1.00 [ 0.27, 3.67 ]
Subtotal (95% CI) 50 25 60.0 % 1.00 [ 0.27, 3.67 ]
Total events: 6 (Antibiotics), 3 (No antibiotics)
Heterogeneity: not applicable
Test for overall effect: Z = 0.0 (P = 1.0)
Total (95% CI) 100 50 100.0 % 1.00 [ 0.36, 2.76 ]
Total events: 10 (Antibiotics), 5 (No antibiotics)
Heterogeneity: Chi2 = 0.0, df = 1 (P = 1.00); I2 =0.0%
Test for overall effect: Z = 0.0 (P = 1.0)
Test for subgroup differences: Chi2 = 0.0, df = 1 (P = 1.00), I2 =0.0%
0.005 0.1 1 10 200
Favours no antibiotics Favours antibiotics
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Analysis 2.2. Comparison 2 Incision and drainage: antibiotic use versus no antibiotic use, Outcome 2 Post-
operative complications.
Review: Treatments for breast abscesses in breastfeeding women
Comparison: 2 Incision and drainage: antibiotic use versus no antibiotic use
Outcome: 2 Post-operative complications
Study or subgroup Antibiotics No antibiotics Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Course of antibiotics
Singla 2002 8/50 6/25 50.0 % 0.67 [ 0.26, 1.71 ]
Subtotal (95% CI) 50 25 50.0 % 0.67 [ 0.26, 1.71 ]
Total events: 8 (Antibiotics), 6 (No antibiotics)
Heterogeneity: not applicable
Test for overall effect: Z = 0.84 (P = 0.40)
2 Single dose of antibiotics
Singla 2002 6/50 6/25 50.0 % 0.50 [ 0.18, 1.39 ]
Subtotal (95% CI) 50 25 50.0 % 0.50 [ 0.18, 1.39 ]
Total events: 6 (Antibiotics), 6 (No antibiotics)
Heterogeneity: not applicable
Test for overall effect: Z = 1.33 (P = 0.18)
Total (95% CI) 100 50 100.0 % 0.58 [ 0.29, 1.17 ]
Total events: 14 (Antibiotics), 12 (No antibiotics)
Heterogeneity: Chi2 = 0.16, df = 1 (P = 0.69); I2 =0.0%
Test for overall effect: Z = 1.53 (P = 0.13)
Test for subgroup differences: Chi2 = 0.16, df = 1 (P = 0.69), I2 =0.0%
0.01 0.1 1 10 100
Favours antibotics Favours no antibiotics
A D D I T I O N A L T A B L E S
Table 1. Summary of characteristics of studies
Study
ID
Total
num-
ber of
partici-
pants
Inter-
ven-
tion
(n)
Com-
pari-
son
(N)
Coun-
try
*Primary out-
comes reported
**Secondary outcomes reported
1 2 3 4 5 6 7 8 9
Eryil-
maz
45 Needle
aspira-
I&
D (n =
Turkey Y N Y N N Y N Y N
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Table 1. Summary of characteristics of studies (Continued)
2005 tion
with-
out ul-
tra-
sound
(n =
22)
23)
Saleem
2008
60 Per-
cuta-
neous
ultra-
sound-
guided
drainage
(n =
30)
I&
D (n =
30)
Pak-
istan
Y Y N Y N Y Y Y N
Singla
2002
150 All
women
under-
went
(I&D)
Antibi-
otics
(Group
1 n
= 50;
Group
2 n =
50)
Con-
trol (n
= 50)
India Y N Y N N N Y N N
Suthar
2012
70 Percu-
ta-
neous
ultra-
sound-
guided
needle
aspira-
tion (n
= 35)
Open
sur-
gical
drainage
(n =
35)
India Y Y Y N N N Y N Y
*Primary and **Secondary outcomes
1. Time to complete resolution.
2. Any continuation of breastfeeding after treatment.
3. Treatment failure .
4. Number of follow-up visits.
5. Duration of continuation of breastfeeding after treatment.
6. Maternal satisfaction with treatment.
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7. Post-operative complications/morbidity.
8. Duration of hospital stay.
9. Adverse events.
I&D: incision and drainage
A P P E N D I C E S
Appendix 1. Search terms for Google Scholar, African Journals Online, ICTRP and dissertation
databases
African Journals Online, ICTRP and dissertation databases
(breastfeed* OR lactation OR lactational OR lactating OR puerper* OR postpartum OR post-partum OR postnatal) AND abscess*
AND (manage* OR therap* OR treat* OR intervent* ) AND random*
Google Scholar
(breastfeed* OR lactation OR lactational OR lactating OR puerper* OR postpartum OR post-partum OR postnatal) AND abscess*
AND (manage* OR therap* OR treat* OR intervent* ) AND random*
Appendix 2. DATA extraction form
SYSTEMATIC REVIEW - LACTATIONAL BREAST ABSCESS
STUDY ELIGIBILITY FORM
STUDY ID:
DATE:
EXTRACTOR (INITIALS):
STUDY REFERENCE:
STUDY ELIGIBILITY
Eligible Not eligible
Participants
Intervention
Comparison
Outcomes
Study design
TRIAL METHODOLOGY
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Study Design/type
Total study duration
Domain Judgment Quotes/comments
Selection bias
Adequate sequence generation
Was the allocation sequence adequately
generated?
High
Low
Unclear
Allocation concealment
Was allocation adequately concealed High
Low
Unclear
Performance Bias
Blinding of participants/providers
Was knowledge of the allocated inter-
ventions adequately prevented during the
study
High
Low
Unclear
Detection Bias
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(Continued)
Blinding of outcome assessors
Was knowledge of the allocated interven-
tions adequately prevented during mea-
surement?
High
Low
Unclear
Attrition bias
Incomplete outcome data addressed
Were incomplete outcome data adequately
addressed?
High
Low
Unclear
Reporting bias
Free of selective reporting
Are reports of the study free of suggestion
of selective outcomes reporting?
High
Low
Unclear
Other bias
Free of other bias
Was the study apparently free of other prob-
lems that could put it at high risk of bias
High
Low
Unclear
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(Continued)
Source: Chapter 8 Assessing risk of bias in included studies. Higgins JPT. Cochrane Handbook for Systematic Review of Interventions
(Higgins 2011).
TRIAL CHARACTERISTICS
Date of study
Total number of participants randomised
Total number of participants analysed
Level of attrition (%)Total number
Setting
Country
Ethics approval obtained
PARTICIPANT CHARACTERISITICS
Age (years)
Gestational age at delivery
Parity
Duration of symptoms at enrolment (days)
Abscess size at enrolment (cm)
Characteristics of breast abscess: e.g. unilateral/bilateral…
Diagnosis of breast abscess
Duration of lactation (months)
Abscess/mastitis-previous pregnancy
Co-morbities (list)
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INTERVENTIONS
Total number of intervention
groups
Details Intervention 1 Intervention 2 Control group
State specific intervention
Number of participants ran-
domised
Number of participants anal-
ysed
Catheter size
Needle size
Intervention details (sufficient
for replication if feasible
OUTCOMES
RESULTS PER OUTCOME
Primary outcome 1:
Collected YES/NO
Reported YES/NO
How was outcome defined
Unit of measurement
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(Continued)
Primary outcome 2
Collected YES/NO
Reported YES/NO
How was outcome defined
Unit of measurement
Primary outcome 3:
Collected YES/NO
Reported YES/NO
How was outcome defined
Unit of measurement
Secondary outcome 1
Collected YES/NO
Reported YES/NO
How was outcome defined
Unit of measurement
Secondary outcome 2
Collected YES/NO
Reported YES/NO
How was outcome defined
Unit of measurement
Secondary outcome 3
Collected YES/NO
Reported YES/NO
How was outcome defined
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(Continued)
Unit of measurement
Secondary outcome 4
Collected YES/NO
Reported YES/NO
How was outcome defined
Unit of measurement
Secondary outcome 5
Collected YES/NO
Reported YES/NO
How was outcome defined
Unit of measurement
OTHER:
Collected YES/NO
Reported YES/NO
How was outcome defined
Unit of measurement
Primary outcome/secondary outcome
Primary outcome 1:
Intervention 1 Intervention 2
Number of participants
Missing participants
Mean (SD) /risk
Primary outcome 2:
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Intervention 1 Intervention 2
Number of participants
Missing participants
Mean (SD)/Risk
Primary outcome 3:
Intervention 1 Intervention 2
Number of participants
Missing participants
Mean (SD)/Risk
Secondary outcome: 1
Intervention1 Intervention2
Number of participants with more than
one visit
Missing participants
Mean (SD)/Risk
Secondary outcome 2
Intervention 1 Intervention 2
Number of participants
Missing participants
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(Continued)
Mean (SD)/Risk
Secondary outcome 3
Intervention 1 Intervention 2
Number of participants
Missing participants
Mean (SD)/Risk
Secondary outcome 4
Intervention 1 Intervention 2
Number of participants
Missing participants
Mean (SD)/Risk
Secondary outcome 5
Intervention 1 Intervention 2
Number of participants
Missing participants
Mean (SD)/Risk
MISCELLANEOUS
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Funding source
Key conclusions of the study
Miscellaneous comments from study authors
References to other relevant studies
Author’s contact details
Correspondence required
Miscellaneous comments by the review authors
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Hayley Irusen is guarantor for the review and she developed the protocol. Anke Rohwer and Taryn Young gave input on the protocol
development and draft. Professor Daniël Wilhelm Steyn commented on the clinical aspects of the protocol and review.
Hayley Irusen was involved in screening the results and eligibility assessment of the studies. She was involved in data extraction, data
management, ’Risk of bias’ assessment, data analysis and data interpretation. She was responsible for writing the initial draft of the
review.
Anke Rohwer as the second author was independently involved in the screening of search results, analysis and interpretation of the
data, and commented on and revised the manuscript.
Taryn Young provided methodological support for the review. She oversaw the project. She assisted in resolving disagreements, con-
tributed to data analysis and interpretation of results and commenting on and revising the manuscript.
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S O U R C E S O F S U P P O R T
Internal sources
• Centre for Evidence-based Health Care, Faculty of Medicine and Health Sciences, Stellenbosch University, South Africa.
External sources
• Department for International Development, UK.
AR and TY are supported in part by the Effective Health Care Research Consortium, which is funded by UKaid from the UK
Government Department for International Development.
D I F F E R E N C E S B E TW E E N P R O T O C O L A N D R E V I E W
There are some differences between our published protocol (Irusen 2013) and the full review - these are detailed below.
Index to thesis in Great Britian and Ireland and Dissonline have not been searched for studies for the review as Stellenbosch University
library does not have access to these databases.
We have changed the third primary outcome ’Resolution of breast abscess’ to ’Treatment failure’. After data extraction, we realised
that ’Treatment failure’ is a more pertinent outcome. We also realised that there was an error in the protocol that neither the review
team, nor the peer reviewers picked up before publication. We intended including the primary outcome ’Resolution of abscess’ and
had added it to the list of primary outcomes. With various iterations and corrections on the protocol within the review team, it was
accidentally deleted. However, in the published protocol, under the heading Measures of treatment effect, we referred to this outcome
under the subheading Dichotomous data’. We thus definitely had the intention of including it in the protocol.
We changed the name of the primary outcome ’Time to resolution of abscess’ to ’Time to resolution of breast abscess’ for clarity.
Future updates of this review may consider including quasi-RCTs and cluster-RCTs due to paucity of data.
Methods for sensitivity analysis has been updated to reflect possible inclusion of cluster-RCTs in future updates of this review.
I N D E X T E R M S
Medical Subject Headings (MeSH)
∗Breast Feeding; Abscess [etiology; ∗therapy]; Biopsy, Fine-Needle [methods]; Breast Diseases [etiology; ∗therapy]; Cephalosporins
[therapeutic use]; Drainage [methods]; Mastitis [etiology; therapy]; Randomized Controlled Trials as Topic; Treatment Failure; Ultra-
sonography, Interventional
MeSH check words
Adult; Female; Humans
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